RESULT_COUNT: 455,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
XON,XON:US,BBG000QL8VH9,Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger,2017-10-19 12:00:00 +0000,https://finance.yahoo.com/news/intrexon-ceo-participate-world-food-120000561.html?.tsrc=rss,"GERMANTOWN, Md., Oct.19, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Randal J. Kirk, Chairman and Chief Executive Officer, will participate in a CEO panel titled ""Consolidation, Innovation, and the Road to Feeding 9 Billion by 2050"" at the Borlaug Dialogue on October 19th at 3:15 pm CT.  Intrexon is committed to utilizing engineered biology to address current and future challenges in feeding a growing population in a sustainable manner."
XON,XON:US,BBG000QL8VH9,Intrexon inks $100M funding deal with billionaire founder Randal Kirk,2017-10-17 19:49:28 +0000,http://finance.yahoo.com/r/36c74890-c882-36c7-9835-74a7719b26a2/intrexon-inks-100m-funding-deal-with-billionaire.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Germantown-based bioengineering company Intrexon Corp. will have access to up to $100 million of new capital through a deal with an affiliate company controlled by its founder and chairman, Randal ""RJ"" Kirk.  Intrexon (XON) announced Monday the company entered into what it called a preferred stock equity facility with Kapital Joe LLC, an entity managed by Third Security LLC, a venture capital firm founded by Kirk.  Kirk, a biotech billionaire, is already Intrexon's biggest backer."
XON,XON:US,BBG000QL8VH9,Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility,2017-10-16 20:13:00 +0000,https://finance.yahoo.com/news/intrexon-corporation-enters-100-million-201300606.html?.tsrc=rss,"GERMANTOWN, Md. , Oct. 16, 2017 /PRNewswire/ --  Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ..."
XON,XON:US,BBG000QL8VH9,Intrexon Crop Protection Achieves Milestone in Development of Pioneering Self-Limiting Fall Armyworm Solution,2017-10-16 12:00:00 +0000,https://finance.yahoo.com/news/intrexon-crop-protection-achieves-milestone-120000656.html?.tsrc=rss,"OXFORD, England, Oct. 16, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the achievement of a key milestone in the development of its innovative solution for control of the agricultural pest fall armyworm (Spodoptera frugiperda) in collaboration with a leading agricultural company.  Intrexon Crop Protection's targeted, biologically-based approach utilizing Oxitec's self-limiting insect technology holds substantial promise to control this major agricultural pest and prevent widespread crop losses, thereby benefitting farmers and enhancing food sustainability."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces First Patient Dosed in New Phase 1 Study of Ad-RTS-hIL-12 plus Veledimex for the Treatment of Pediatric Brain Tumors,2017-10-16 11:00:00 +0000,https://finance.yahoo.com/news/ziopharm-oncology-announces-first-patient-110000538.html?.tsrc=rss,"BOSTON, Oct. 16, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company developing new gene and cell-based immunotherapies for cancer, today announced that the first patient has been dosed in a new ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Announces Three Presentations at the 2017 Annual Meeting of the Society for Neuro-Oncology,2017-10-12 11:00:00 +0000,https://finance.yahoo.com/news/ziopharm-announces-three-presentations-2017-110000633.html?.tsrc=rss,"BOSTON, Oct. 12, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on developing gene and cell-based immunotherapies for cancer, today announced that three abstracts highlighting data ..."
XON,XON:US,BBG000QL8VH9,Oxitec do Brasil Receives Prestigious Award for Innovation and Impact,2017-10-11 12:41:00 +0000,https://finance.yahoo.com/news/oxitec-brasil-receives-prestigious-award-124100295.html?.tsrc=rss,"Oxitec do Brasil, a subsidiary of Oxitec Ltd, UK, has been presented with the Empreendetec Award in the enterprise category recognizing the results of Oxitec's technology and its contribution to the Piracicaba community and Brazil.  The awarding body, ESALQTec from Esalq/USP (Luiz de Queiroz Agriculture College from University of São Paulo), is a technological incubator that brings together companies with innovative projects in the areas of agriculture, biology and information technology."
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-10-09 12:03:58 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120358398.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
XON,XON:US,BBG000QL8VH9,3 Stocks That Could Lose You a Lot of Money,2017-10-08 16:51:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vb8ygPV7Ou4/3-stocks-that-could-lose-you-a-lot-of-money-cm856779,Even the most successful investors swing and miss from time to time It s a big messy world out there and no one has all the information they need to scout out only winning stocks for their portfolios All individual investors can easily relate That said it s probably best to
XON,XON:US,BBG000QL8VH9,Intrexon Corporation (XON): How Does It Impact Your Portfolio?,2017-10-07 00:19:12 +0000,https://finance.yahoo.com/news/intrexon-corporation-xon-does-impact-001912710.html?.tsrc=rss,"For Intrexon Corporation’s (NYSE:XON) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measures XON’sRead More..."
XON,XON:US,BBG000QL8VH9,Analysts Are Expecting Gas Fermentation to Be Huge for Intrexon. Here's Why They're Wrong.,2017-10-06 16:44:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CvNBff3cDvM/analysts-are-expecting-gas-fermentation-to-be-huge-for-intrexon-heres-why-theyre-wrong-cm856327,Although most of the market cap awarded to synthetic biology conglomerate Intrexon NYSE XON is derived from its potential in healthcare analysts are beginning to eye the potential for perhaps its leading non pharma development stage technology platform gas fermentation
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : October 6, 2017",2017-10-06 15:11:47 +0000,http://finance.yahoo.com/r/4cdd9486-f67e-3362-b1de-e95363d2dd14/etfs-with-exposure-to-intrexon-corp-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Analysts Are Expecting Gas Fermentation to Be Huge for Intrexon. Here&apos;s Why They&apos;re Wrong.,2017-10-06 15:05:00 +0000,http://finance.yahoo.com/r/645bb3fb-b052-3e3b-b21a-d21130c990c6/analysts-are-expecting-gas-fermentation-to-be-huge.aspx?yptr=yahoo&.tsrc=rss,Intrexon has been touting the potential of a new technology platform to alter global chemical production.
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : October 5, 2017",2017-10-05 12:09:53 +0000,http://finance.yahoo.com/r/634c04af-be5c-39f2-a382-3b150cd93d21/intrexon-corp-breached-its-50-day-moving-average-in-a-bullish-manner-xon-us-october-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intrexon Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Transfer of Regulatory Jurisdiction for Oxitec's Self-limiting Friendly™ Aedes in the United States,2017-10-04 17:00:00 +0000,https://finance.yahoo.com/news/transfer-regulatory-jurisdiction-oxitecs-self-170000903.html?.tsrc=rss,"OXFORD, England , October 4, 2017 /PRNewswire/ -- FDA issues final Guidance for Industry , transferring regulatory authority to EPA   Following new Guidance issued by the U.S. Food and Drug Administration's ..."
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-10-03 12:03:43 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120343191.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
XON,XON:US,BBG000QL8VH9,Fibrocell to Present at 2017 Cell & Gene Meeting on the Mesa,2017-10-02 20:30:00 +0000,https://finance.yahoo.com/news/fibrocell-present-2017-cell-gene-203000754.html?.tsrc=rss,"EXTON, Pa., Oct. 02, 2017-- Fibrocell Science, Inc., today announced that John Maslowski, President and Chief Executive Officer of Fibrocell, will present at 3:00 pm PDT on Wednesday, October 4 at the ..."
XON,XON:US,BBG000QL8VH9,5 Incredible Synthetic Biology Holy Grails That Could Change the World,2017-10-01 12:29:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N3tFN3hOE8k/5-incredible-synthetic-biology-holy-grails-that-could-change-the-world-cm853527,Biotechnology has come a long way since 1978 when Herbert Boyer successfully demonstrated that human insulin could be produced from bacteria engineered with recombinant DNA The breakthrough technology pushed a little known company called Genentech into the spotlight and forever
XON,XON:US,BBG000QL8VH9,5 Incredible Synthetic Biology Holy Grails That Could Change the World,2017-10-01 11:03:00 +0000,http://finance.yahoo.com/r/9c508371-9af4-3393-b0f6-95de1ce84390/5-incredible-synthetic-biology-holy-grails-that-co.aspx?yptr=yahoo&.tsrc=rss,"Investors are still waiting for next-generation biotech to deliver on its enormous promise and potential, but just one of these Holy Grails would make the wait worth it."
XON,XON:US,BBG000QL8VH9,"ZIOPHARM Oncology Appoints David Mauney, M.D., as Executive Vice President and Chief Business Officer",2017-09-28 20:32:29 +0000,https://finance.yahoo.com/news/ziopharm-oncology-appoints-david-mauney-203229374.html?.tsrc=rss,"BOSTON, Sept. 28, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focusing on new immunotherapies, announces the appointment of David Mauney, M.D., as Executive Vice President and Chief Business ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa,2017-09-26 12:00:00 +0000,https://finance.yahoo.com/news/fibrocell-reports-interim-results-phase-120000582.html?.tsrc=rss,–FCX-007 well-tolerated through 12 weeks post-administration with encouraging safety and positive early trends noted in wound healing and pharmacology signals–. –Data Safety Monitoring Board recommends ...
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : September 25, 2017",2017-09-25 14:48:05 +0000,http://finance.yahoo.com/r/37225525-4c9c-3eff-bac5-7052cba50929/etfs-with-exposure-to-intrexon-corp-september-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Why GMO Crops (Probably) Can't Compete for This $22 Billion Ingredient Opportunity,2017-09-23 13:48:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BLUFxcnz1TM/why-gmo-crops-probably-cant-compete-for-this-22-billion-ingredient-opportunity-cm850005,You may not realize it yet but the bioeconomy is at a historic crossroads The world s largest agricultural companies are on the cusp of developing genetically engineered crops capable of producing novel ingredients for animal feeds which are currently sourced from supply
XON,XON:US,BBG000QL8VH9,All You Need To Know About Intrexon Corporation’s (XON) Financial Health,2017-09-20 11:27:20 +0000,https://finance.yahoo.com/news/know-intrexon-corporation-xon-financial-112720557.html?.tsrc=rss,"Mid-caps stocks, like Intrexon Corporation (NYSE:XON) with a market capitalization of $2.35B, aren’t the focus of most investors who prefer to direct their investments towards either large-cap or small-cap stocks.Read More..."
XON,XON:US,BBG000QL8VH9,Oxitec to Build State-of-the-Art Mosquito Egg Production Unit,2017-09-19 15:00:00 +0000,https://finance.yahoo.com/news/oxitec-build-state-art-mosquito-150000599.html?.tsrc=rss,"Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation (XON), today announced plans to build its first centralized Friendly™ Aedes egg production unit, with the capacity to generate one billion mosquito eggs per week, in Oxfordshire, UK.  The announcement comes as Randal J. Kirk, Intrexon's Chairman and CEO, joined Prime Minister Theresa May at a roundtable event in New York City for a discussion amongst a small group of CEOs regarding plans for investment and growth in Britain."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces Updated Findings from Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma Presented at American Academy of Neurological Surgery Annual Meeting,2017-09-18 12:00:00 +0000,https://finance.yahoo.com/news/ziopharm-oncology-announces-updated-findings-120000504.html?.tsrc=rss,"BOSTON, Sept. 18, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that updated data from a subset of patients in its Phase 1 multicenter study ..."
XON,XON:US,BBG000QL8VH9,The Math Shows FBT Can Go To $140,2017-09-15 13:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NgWaY5HNkIk/the-math-shows-fbt-can-go-to-140-cm846165,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : September 14, 2017",2017-09-14 23:32:05 +0000,http://finance.yahoo.com/r/4ab27d66-754b-3514-9825-661c31b23129/etfs-with-exposure-to-intrexon-corp-september-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Is Intrexon Corporation Stock Now a Bargain?,2017-09-13 16:36:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P7qs6LbG2DA/is-intrexon-corporation-stock-now-a-bargain-cm845142,What happened According to data from S amp P Global Market Intelligence Intrexon Corporation NYSE XON a synthetic biology company saw its shares dip by 7 72 last month The company s shares struggled after a disappointing second quarter earnings release early in the
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017",2017-09-13 15:50:49 +0000,http://finance.yahoo.com/r/a8da5855-c179-3877-b72d-7855a7f6ac59/intrexon-corp-xon-us-earnings-analysis-q2-2017-by-the-numbers-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Intrexon Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Intrexon Corp. – ZIOPHARM Oncology, Inc., Eli Lilly and Company, Thermo Fisher Scientific Inc., Fibrocell Science, Inc. and Synthetic Biologics, Inc. (ZIOP-US, LLY-US, TMO-US, FCSC-US and SYN-US) that have ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Is Intrexon Corporation Stock Now a Bargain?,2017-09-13 15:00:00 +0000,http://finance.yahoo.com/r/01f0adf4-ff48-34b8-8cb2-36f8931397c8/is-intrexon-corporation-stock-now-a-bargain.aspx?yptr=yahoo&.tsrc=rss,"As Intrexon&apos;s losses mount, investors begin to hit the exits."
XON,XON:US,BBG000QL8VH9,ZIOPHARM to Present at the Rodman & Renshaw 19th Annual Global Investment Conference,2017-09-05 11:00:00 +0000,https://finance.yahoo.com/news/ziopharm-present-rodman-renshaw-19th-110000802.html?.tsrc=rss,"BOSTON, Sept. 05, 2017-- ZIOPHARM Oncology, Inc. today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Rodman & Renshaw 19 th Annual Global Investment Conference ..."
XON,XON:US,BBG000QL8VH9,Oxitec's Innovative Solution to Tackle Growing Diamondback Moth Pest Issue Begins Field Trials,2017-09-05 07:00:00 +0000,https://finance.yahoo.com/news/oxitecs-innovative-solution-tackle-growing-070000404.html?.tsrc=rss,"Oxitec Ltd, a wholly-owned subsidiary of Intrexon Corporation (XON), today announced that field trials of its genetically engineered diamondback moth have commenced following the Finding Of No Significant Impact (FONSI) recently issued by the US Department of Agriculture (USDA)."
XON,XON:US,BBG000QL8VH9,Pfizer's Acute Leukemia Drug Mylotarg Approved by the FDA,2017-09-04 15:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dUP9K9NnRcE/pfizers-acute-leukemia-drug-mylotarg-approved-by-the-fda-cm840773,Pfizer Inc PFE announced that the FDA has granted approval to Mylotarg for adult patients with newly diagnosed CD33 positive acute myeloid leukemia AML The drug also received approval to treat relapsed or refractory CD33 positive AML in adults as well as children 2 years and older
XON,XON:US,BBG000QL8VH9,The Simple Reason I Won&apos;t Buy Intrexon,2017-09-01 13:02:00 +0000,http://finance.yahoo.com/r/396d00aa-50c5-3ffe-8baf-eaa50021b1ad/the-simple-reason-i-wont-buy-intrexon.aspx?yptr=yahoo&.tsrc=rss,"By hiding behind complexity, the synthetic biology conglomerate is taking the first steps down a troubling path."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology to Participate at Upcoming CAR-TCR Summit,2017-09-01 11:05:41 +0000,https://finance.yahoo.com/news/ziopharm-oncology-participate-upcoming-car-110541462.html?.tsrc=rss,"BOSTON, Sept. 01, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that the Company will participate at the upcoming CAR-TCR Summit 2017. The ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Participate in Upcoming Investor Conferences,2017-08-31 20:01:00 +0000,https://finance.yahoo.com/news/intrexon-participate-upcoming-investor-conferences-200100357.html?.tsrc=rss,"GERMANTOWN, Md. , Aug. 31, 2017 /PRNewswire/ --  Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ..."
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-08-31 12:07:07 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120707291.html?.tsrc=rss,"Short interest is moderately high for XON with between 10 and 15% of shares outstanding currently on loan.  ETFs that hold XON had net inflows of $709 million over the last one-month.  Index (PMI) data, output in the Healthcare sector is rising."
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-08-30 12:02:04 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120204125.html?.tsrc=rss,Short interest is moderately high for XON with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  ETFs that hold XON had net inflows of $709 million over the last one-month.
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-08-22 12:04:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120447529.html?.tsrc=rss,Short interest is moderately high for XON with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  The net inflows of $282 million over the last one-month into ETFs that hold XON are among the lowest of the last year and appear to be slowing.
XON,XON:US,BBG000QL8VH9,Weekly CEO Buys Highlights,2017-08-21 17:43:31 +0000,https://finance.yahoo.com/news/weekly-ceo-buys-highlights-174331438.html?.tsrc=rss,"Insiders invest in Energy Transfer Partners, American Assets, Intrexon, Hostess and Akamai"
XON,XON:US,BBG000QL8VH9,Intrexon Corp (XON) CEO Randal J Kirk Bought $2.5 million of Shares,2017-08-15 10:34:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BCMluOgSp2Y/intrexon-corp-xon-ceo-randal-j-kirk-bought-25-million-of-shares-cm832006,CEO of Intrexon Corp XON Randal J Kirk bought 132 625 shares of XON on 08 11 2017 at an average price of 18 85 a share The total cost of this purchase was 2 5 million CEO of Intrexon Corp XON Randal J Kirk bought 132 625 shares of XON on 08 11 2017 at an average price of 18 85
XON,XON:US,BBG000QL8VH9,Intrexon Corp (XON) CEO Randal J Kirk Bought $2.5 million of Shares,2017-08-14 15:15:24 +0000,https://finance.yahoo.com/news/intrexon-corp-xon-ceo-randal-151524649.html?.tsrc=rss,"CEO of Intrexon Corp (NYSE:XON) Randal J Kirk bought 132,625 shares of XON on 08/11/2017 at an average price of $18.85 a share."
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 9-Aug-17 9:30pm GMT,2017-08-13 02:25:54 +0000,https://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-031237331.html?.tsrc=rss,Q2 2017 Intrexon Corp Earnings Call
XON,XON:US,BBG000QL8VH9,Intrexon Depended on 1 Customer for 58% of First-Half 2017 Revenue Growth,2017-08-11 14:38:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-o6fyTErLfI/intrexon-depended-on-1-customer-for-58-of-first-half-2017-revenue-growth-cm830881,The single biggest problem facing engineered biology conglomerate Intrexon NYSE XON heading into the second quarter of 2017 was its dependency on small and micro cap companies for a significant portion of its total revenue and nearly all of its revenue growth These companies
XON,XON:US,BBG000QL8VH9,Intrexon Depended on 1 Customer for 58% of First-Half 2017 Revenue Growth,2017-08-11 13:34:00 +0000,http://finance.yahoo.com/r/dd562b97-7812-36d6-b76f-2db55d8db0a8/intrexon-depended-on-1-customer-for-58-of-first-ha.aspx?yptr=yahoo&.tsrc=rss,"Start-ups created for and by Intrexon accounted for another 54% of revenue growth. Yes, those add up to more than 100%."
XON,XON:US,BBG000QL8VH9,Today's Research Reports on Trending Tickers: NetEase Inc. and Intrexon Corporation,2017-08-11 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000760.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 11, 2017 / U.S. markets fell for the third consecutive session Thursday amidst growing geopolitical tensions between the U.S. and North Korea. The Dow Jones Industrial ..."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q2 Loss Narrower than Expected, Revenues Miss",2017-08-10 22:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ofh_DwFM_C8/intrexon-xon-q2-loss-narrower-than-expected-revenues-miss-cm830598,Intrexon Corporation XON incurred loss of 16 cents per share in the second quarter of 2017 which was narrower than the Zacks Consensus Estimate loss of 21 cents Total revenue came in at 54 4 million in the quarter up 4 year over year Reported revenues missed the Zacks Consensus Estimate
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q2 Loss Narrower than Expected, Revenues Miss",2017-08-10 20:28:08 +0000,https://finance.yahoo.com/news/intrexon-xon-q2-loss-narrower-202808367.html?.tsrc=rss,Intrexon Corporation (XON) incurred narrower than expected loss and missed revenue estimates in Q2.
XON,XON:US,BBG000QL8VH9,Intrexon Announces Second Quarter and First Half 2017 Financial Results,2017-08-09 20:05:00 +0000,https://finance.yahoo.com/news/intrexon-announces-second-quarter-first-200500509.html?.tsrc=rss,"- Quarterly GAAP revenues of $54.4 million and net loss attributable to Intrexon of $18.7 million including non-cash charges of $17.4 million - - Adjusted EBITDA of $(2.0) million - GERMANTOWN, Md. , Aug. ..."
XON,XON:US,BBG000QL8VH9,"Earnings Reaction History: Intrexon Corporation, 37.5% Follow-Through Indicator, 8.7% Sensitive",2017-08-09 18:55:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JHG62eqVEqg/earnings-reaction-history-intrexon-corporation-375-follow-through-indicator-87-sensitive-cm829747,Expected Earnings Release 08 09 2017 After hoursExpected Earnings Release 08 09 2017 After hours Avg Extended Hours Dollar Volume 1 978 750Avg Extended Hours Dollar Volume 1 978 750 Intrexon Corporation XON is due to issue its quarterly earnings report in the upcoming extended
XON,XON:US,BBG000QL8VH9,See what the IHS Markit Score report has to say about Intrexon Corp.,2017-08-09 12:05:02 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120502121.html?.tsrc=rss,"Short interest is moderately high for XON with between 10 and 15% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Investors are committing new capital to ETFs that hold XON at an increasing rate, with the one-month net inflow having reached $1.46 billion."
XON,XON:US,BBG000QL8VH9,Oversold Conditions For Intrexon (XON),2017-08-08 21:33:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GPKkECxPCIM/oversold-conditions-for-intrexon-xon-cm829036,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
XON,XON:US,BBG000QL8VH9,"AquaBounty Technologies, Inc. Results for the second quarter and first half ended June 30, 2017",2017-08-04 20:30:00 +0000,https://finance.yahoo.com/news/aquabounty-technologies-inc-results-second-203000668.html?.tsrc=rss,"MAYNARD, Mass, Aug. 04, 2017-- AquaBounty Technologies, Inc., a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation, ..."
XON,XON:US,BBG000QL8VH9,Here's How Intrexon Might Prove Me Wrong,2017-08-04 15:03:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GEUsfPktvik/heres-how-intrexon-might-prove-me-wrong-cm827186,I ve been quick to point out when marketing hype doesn t match up with what s realistically possible from a technical standpoint Unfortunately in my opinion there have been many such instances in the early stages of the industrial biotech industry That s why I ve strongly argued
XON,XON:US,BBG000QL8VH9,Here&apos;s How Intrexon Might Prove Me Wrong,2017-08-04 13:08:00 +0000,http://finance.yahoo.com/r/ac27d987-0ef7-333d-bd6f-034ec74a4137/heres-how-intrexon-might-prove-me-wrong.aspx?yptr=yahoo&.tsrc=rss,Can it really convert cheap natural gas to valuable chemicals at double digit gross margin?
XON,XON:US,BBG000QL8VH9,What's in Store for Intrexon (XON) in this Earnings Season?,2017-08-02 16:59:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QWpiAdpV5BQ/whats-in-store-for-intrexon-xon-in-this-earnings-season-cm825876,Intrexon Corporation XON is expected to report second quarter 2017 results on Aug 8 Last quarter the company saw a negative earnings surprise of 13 04 In fact it missed expectations thrice in the trailing four quarters and met estimates once with an average negative surprise of 13
XON,XON:US,BBG000QL8VH9,What&apos;s in Store for Intrexon (XON) in this Earnings Season?,2017-08-02 14:26:02 +0000,https://finance.yahoo.com/news/apos-store-intrexon-xon-earnings-142602962.html?.tsrc=rss,"Intrexon Corporation (XON) will focus on the development of its pipeline candidates- FCX-013, FCX-007 in Q2."
XON,XON:US,BBG000QL8VH9,Intrexon to Announce Second Quarter and First Half 2017 Financial Results on August 9th,2017-08-02 12:00:00 +0000,https://finance.yahoo.com/news/intrexon-announce-second-quarter-first-120000385.html?.tsrc=rss,"GERMANTOWN, Md. , Aug. 2, 2017 /PRNewswire/ --   Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ..."
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Wednesday, August 9, 2017 to Discuss Second Quarter 2017 Financial Results and Recent Operational Highlights",2017-08-02 12:00:00 +0000,https://finance.yahoo.com/news/fibrocell-host-conference-call-webcast-120000706.html?.tsrc=rss,"EXTON, Pa., Aug. 02, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will report financial results ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. – Value Analysis (NYSE:XON) : August 1, 2017",2017-08-01 00:12:51 +0000,http://finance.yahoo.com/r/65819c33-c747-36a0-8adf-45d469bc63cd/intrexon-corp-value-analysis-nysexon-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Intrexon Corp. a score of 59. Our analysis is based on comparing Intrexon Corp. with the following peers – ZIOPHARM Oncology, Inc., Eli Lilly and Company, Odyssey Marine Exploration, Inc., Thermo Fisher Scientific Inc., Fibrocell Science, Inc. and Synthetic Biologics, Inc. (ZIOP-US, LLY-US, OMEX-US, TMO-US, FCSC-US and ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Reports Second Quarter 2017 Financial Results and Provides Update on Recent Activities,2017-07-31 20:05:00 +0000,https://finance.yahoo.com/news/ziopharm-oncology-reports-second-quarter-200500255.html?.tsrc=rss,"BOSTON, July 31, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced its financial results for the second quarter ended June 30, 2017, and provided ..."
XON,XON:US,BBG000QL8VH9,"Commit To Buy Intrexon Corp At $18, Earn 14.9% Annualized Using Options",2017-07-26 16:56:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/en3vTD4elws/commit-to-buy-intrexon-corp-at-18-earn-149-annualized-using-options-cm821774,Investors eyeing a purchase of Intrexon Corp Symbol XON shares but tentative about paying the going market price of 23 20 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2018
XON,XON:US,BBG000QL8VH9,"ZIOPHARM Oncology to Host Second-Quarter 2017 Financial Results and Corporate Update Conference Call on July 31, 2017 at 4:30 p.m. ET",2017-07-24 11:00:00 +0000,https://finance.yahoo.com/news/ziopharm-oncology-host-second-quarter-110000409.html?.tsrc=rss,"BOSTON, July 24, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will host a conference call and webcast slide presentation on Monday, ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : July 17, 2017",2017-07-17 14:04:49 +0000,http://finance.yahoo.com/r/ddb47a6b-9c56-33d7-b7ce-66374c5a483d/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-july-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intrexon Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Intrexon Corp (XON) Shares Cross Above 200 DMA,2017-07-13 21:48:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dnkSYjRI9_s/intrexon-corp-xon-shares-cross-above-200-dma-cm815875,In trading on Thursday shares of Intrexon Corp Symbol XON crossed above their 200 day moving average of 24 22 changing hands as high as 24 45 per share Intrexon Corp shares are currently trading up about 3 on the day The chart below shows the one year performance of XON shares versus
XON,XON:US,BBG000QL8VH9,Pfizer's Mylotarg Recommended by FDA Advisory Committee,2017-07-12 16:48:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/foVV7GO0ATc/pfizers-mylotarg-recommended-by-fda-advisory-committee-cm815128,Pfizer Inc PFE announced that the FDA s Oncologic Drug Advisory Committee ODAC voted in favor of Mylotarg for the treatment of patients with newly diagnosed CD33 positive acute myeloid leukemia AML The committee believes that the ALFA 0701 study investigating Mylotarg provides
XON,XON:US,BBG000QL8VH9,3 Biggest Challenges Facing This Billionaire-Led Stock,2017-07-12 13:47:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rmFAovZxsx4/3-biggest-challenges-facing-this-billionaire-led-stock-cm814878,Some years ago billionaire Randal J Kirk took over a relatively unknown biopharma company called Intrexon NYSE XON invested hundreds of millions of dollars of his own money into it and gradually built it into an engineered biology conglomerate valued at over 3 billion today
XON,XON:US,BBG000QL8VH9,3 Biggest Challenges Facing This Billionaire-Led Stock,2017-07-12 12:10:00 +0000,http://finance.yahoo.com/r/adaf08a3-cd02-3edd-9a2d-c1b620eb1dbc/3-biggest-challenges-facing-this-billionaire-led-s.aspx?yptr=yahoo&.tsrc=rss,Investors should be aware of these obstacles facing Intrexon stock.
XON,XON:US,BBG000QL8VH9,10 Low-Key Companies That Are Changing Aquaculture,2017-07-11 16:46:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ese5ShwV2xg/10-low-key-companies-that-are-changing-aquaculture-cm814486,There may be a lot of fish in the sea but wild fish stocks are still a finite resource that needs to be properly managed In fact global catch volumes from wild fisheries have remained virtually unchanged since 1988 Civilization has only been able to meet growing demand for fish
XON,XON:US,BBG000QL8VH9,"Oxitec Launching Friendly™ Aedes Project in Juiz de Fora, Brazil",2017-07-11 14:00:00 +0000,https://finance.yahoo.com/news/oxitec-launching-friendly-aedes-project-140000763.html?.tsrc=rss,"Oxitec Ltd., a wholly-owned subsidiary of Intrexon Corporation (XON), today announced Oxitec do Brasil has signed a contract to launch the Friendly™ Aedes Project in Juiz de Fora, Brazil.  Juiz de Fora becomes the second Brazilian municipality and the first city in Minas Gerais state to deploy innovative Friendly™ Aedes in the fight against dangerous Aedes aegypti mosquitoes - the primary vector of dengue, Zika, chikungunya and yellow fever."
XON,XON:US,BBG000QL8VH9,7 Wacky Sources of Alternative Energy,2017-07-11 11:45:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iLkx4PrmHHA/7-wacky-sources-of-alternative-energy-cm814199,Image source Getty Images The argument for human induced climate change can be boiled down to some pretty simple math The fossil fuels we ve consumed since the Industrial Revolution took tens of millions of years to create through biological and geological processes We ve
XON,XON:US,BBG000QL8VH9,7 Wacky Sources of Alternative Energy,2017-07-11 10:00:00 +0000,http://finance.yahoo.com/r/5618eddf-31e3-394d-8bf1-6298de34bfa6/7-wacky-sources-of-alternative-energy.aspx?yptr=yahoo&.tsrc=rss,These crazy power sources could revolutionize the energy industry -- or they could prove to be nothing more than curious boondoggles.
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : July 10, 2017",2017-07-10 19:32:44 +0000,http://finance.yahoo.com/r/6b3a5fec-1311-3f03-961f-260afa43b6d2/etfs-with-exposure-to-intrexon-corp-july-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Why Intrexon Stock Rose 10.4% in June,2017-07-10 17:47:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3nKXTacXiXM/why-intrexon-stock-rose-104-in-june-cm813914,What happened Shares of Intrexon NYSE XON a conglomerate that has multiple projects related to engineered biology in the works jumped 10 in June according to data from S amp P Global Market Intelligence So what The share price jump was most likely caused by
XON,XON:US,BBG000QL8VH9,Why Intrexon Stock Rose 10.4% in June,2017-07-10 16:26:06 +0000,http://finance.yahoo.com/r/0303b8c4-4812-3ac0-b185-c8372f2cd8f7/why-intrexon-stock-rose-104-in-june.aspx?yptr=yahoo&.tsrc=rss,It was another busy month for the synthetic biology company.
XON,XON:US,BBG000QL8VH9,Oxitec's Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment,2017-07-06 12:30:00 +0000,https://finance.yahoo.com/news/oxitecs-friendly-aedes-mosquito-receives-123000081.html?.tsrc=rss,"OXFORD, England, July 6, 2017 /PRNewswire/ -- The National Institute of Public Health and the Environment (RIVM) in the Netherlands today published its ""Technical evaluation of a potential release of OX513A Aedes aegypti mosquitoes on the island of Saba"", which positively concludes a vector control program using Oxitec's Friendly™ Aedes aegypti mosquitoes would pose negligible risks to human health and the environment.  RIVM's GMO office undertook its biosafety evaluation of Oxitec's Friendly™ self-limiting mosquito technology following the guidance for risk assessment of genetically modified animals by the European Food Safety Authority (EFSA) and the European risk assessment framework, which is considered one of the most robust and thorough biosafety frameworks globally.  Additionally this independent review reflected guidance from the World Health Organization (WHO) for testing of genetically modified mosquitoes as well as the Cartagena Protocol on the Biosafety to the Convention on Biological Diversity."
XON,XON:US,BBG000QL8VH9,"Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen",2017-06-29 19:30:00 +0000,https://finance.yahoo.com/news/intrexon-appoints-helen-sabzevari-ph-193000228.html?.tsrc=rss,"GERMANTOWN, Md., June 29, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the appointment of Helen Sabzevari, Ph.D., Senior Vice President, Intrexon Health Therapeutics as well as Head of Research and Development of Precigen Inc.  She will report directly to Randal J. Kirk, Chief Executive Officer of Intrexon.  Dr. Sabzevari brings extensive expertise in research and development of immunotherapy-based therapeutics as well as experience translating novel treatments from pre-clinical stage into the clinic.  She served as Senior Vice President of Immuno-Oncology as well as Global Head of Immunotherapy, Oncology, Global Research and Early Development at EMD Serono (a subsidiary of Merck KGaA, Darmstadt, Germany)."
XON,XON:US,BBG000QL8VH9,Investors slowly start to push climate change up their agenda,2017-06-29 16:08:16 +0000,https://finance.yahoo.com/news/investors-slowly-start-push-climate-160816514.html?.tsrc=rss,"LONDON/OSLO, June 29  (Reuters) - Investors are slowly  starting to push companies to reduce their carbon footprint and  help the world meet targets on limiting global warming that were  agreed in the 2015 Paris climate talks.  Energy firms have faced shareholder demands to do more to  curb carbon emissions, while some pension funds are demanding  more commitment to climate goals from firms they invest in.  ""Lots of investors are looking to align their investments  with a 2 degrees world."
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : June 26, 2017",2017-06-26 21:16:56 +0000,http://finance.yahoo.com/r/dc8129b9-64a2-3804-8ead-275ff7c3909b/etfs-with-exposure-to-intrexon-corp-june-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Intrexon (XON) Shares Cross Above 200 DMA,2017-06-22 16:22:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sGqc5-jxG0c/intrexon-xon-shares-cross-above-200-dma-cm806918,In trading on Thursday shares of Intrexon Corp Symbol XON crossed above their 200 day moving average of 24 41 changing hands as high as 24 73 per share Intrexon Corp shares are currently trading up about 3 on the day The chart below shows the one year performance of XON shares versus
XON,XON:US,BBG000QL8VH9,What Will Happen to Intrexon's Natural Gas-to-Chemicals Business?,2017-06-21 16:23:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_JgyoO5OBQg/what-will-happen-to-intrexons-natural-gas-to-chemicals-business-cm806252,Imagine an engineered bacteria that can be fed natural gas and churn out low cost transportation fuels capable of displacing billions of gallons of gasoline per year It may sound like science fiction but it s among the many projects being developed by engineered biology
XON,XON:US,BBG000QL8VH9,What Will Happen to Intrexon&apos;s Natural Gas-to-Chemicals Business?,2017-06-21 15:15:00 +0000,http://finance.yahoo.com/r/3b1259b5-eba5-3ef2-b78c-e2aa116a3fe3/what-will-happen-to-intrexons-natural-gas-to-chemi.aspx?yptr=yahoo&.tsrc=rss,Investors and Wall Street analysts are swooning over the company&apos;s novel approach to fuels and chemicals manufacturing. Scientists are more skeptical -- and for good reason.
XON,XON:US,BBG000QL8VH9,"ETFs with exposure to Intrexon Corp. : June 16, 2017",2017-06-16 20:27:41 +0000,http://finance.yahoo.com/r/2e8c015b-4697-3a73-ab91-d7e4091dfa58/etfs-with-exposure-to-intrexon-corp-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Intrexon Corp. Here are 5 ETFs with the largest exposure to XON-US. Comparing the performance and risk of Intrexon Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,3 Stocks Billionaires Own,2017-06-16 16:10:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFPtAohBWRY/3-stocks-billionaires-own-cm804428,The number of billionaires on planet Earth hit 2 043 in 2016 topping 2 000 for the first time ever according to Forbes They had a combined net worth of brace yourself 7 7 trillion We may not be able to replicate their success on the same order of magnitude but we may be
XON,XON:US,BBG000QL8VH9,3 Stocks Billionaires Own,2017-06-16 14:05:00 +0000,http://finance.yahoo.com/r/e9fbabc9-a5ef-397e-a900-6c9fc6d425ba/3-stocks-billionaires-own.aspx?yptr=yahoo&.tsrc=rss,"If billionaires own Intrexon, CVR Energy, and Kinder Morgan, then does that mean you should give these stocks a closer look for your portfolio?"
XON,XON:US,BBG000QL8VH9,Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition,2017-06-16 13:15:00 +0000,https://finance.yahoo.com/news/intrexon-integrates-leading-adenoviral-gene-131500696.html?.tsrc=rss,"With the addition of GenVec's AdenoVerse™ technology and accomplished team, Intrexon intends to create the next generation of adenoviral (AdV) delivery with significantly higher payload capacity that exceeds 30kb, as compared to current viral delivery methods ranging from 4.5kb – 9kb, through a scalable manufacturing platform utilizing helper-dependent adenovirus.  Additionally Intrexon's RheoSwitch Therapeutic System® platform combined with GenVec's AdV-based technology is projected to accelerate its ability to develop cutting-edge gene therapies that regulate in vivo expression of one or several therapeutic effectors.  GenVec's selection of vector origins and serotypes as well as know-how in specifying cellular and tissue targets is expected to expedite the design and production of vectors that complement Intrexon's multigene programming and keen focus on safety with limited off-target effect."
XON,XON:US,BBG000QL8VH9,BP's Dudley seen reigning for years to restore major's might,2017-06-15 10:12:44 +0000,https://finance.yahoo.com/news/bps-dudley-seen-reigning-years-101244654.html?.tsrc=rss,"When BP boss Bob Dudley  clinched a final deal to settle litigation over the deadly  Deepwater Horizon disaster, many oil industry executives and  investors thought his mission was accomplished.  In fact he plans to oversee an  ambitious expansion plan and stay at the helm of the British oil  major until at least the end of the decade, according to sources  familiar with the matter.  When Dudley finally decides to go, there will no shortage of  candidates to take his place, however."
XON,XON:US,BBG000QL8VH9,Why Is Intrexon (XON) Down 4.1% Since the Last Earnings Report?,2017-06-15 09:08:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pafns8aWpGE/why-is-intrexon-xon-down-41-since-the-last-earnings-report-cm803635,It has been about a month since the last earnings report for Intrexon Corporation XON Shares have lost about 4 1 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
XON,XON:US,BBG000QL8VH9,Why Is Intrexon (XON) Down 4.1% Since the Last Earnings Report?,2017-06-15 07:07:07 +0000,https://finance.yahoo.com/news/why-intrexon-xon-down-4-070707288.html?.tsrc=rss,Intrexon (XON) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017",2017-06-14 13:42:37 +0000,http://finance.yahoo.com/r/e9471f63-8d60-365b-8e1f-09e288346293/intrexon-corp-xon-us-earnings-analysis-q1-2017-by-the-numbers-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Intrexon Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Intrexon Corp. – ZIOPHARM Oncology, Inc., Eli Lilly and Company, Odyssey Marine Exploration, Inc., Thermo Fisher Scientific Inc., Fibrocell Science, Inc. and Synthetic Biologics, Inc. (ZIOP-US, LLY-US, OMEX-US, TMO-US, ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,AquaBounty Acquires Fish Farming Facility in Indiana,2017-06-13 11:00:00 +0000,https://finance.yahoo.com/news/aquabounty-acquires-fish-farming-facility-110000860.html?.tsrc=rss,"MAYNARD, Mass., June 13, 2017 /PRNewswire/ -- AquaBounty Technologies, Inc. (AQB) (""AquaBounty"" or the ""Company""), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation (XON), announces that it has entered into an agreement to purchase certain assets of Bell Fish Company, including its farming facility in Albany, Indiana, for $14.0 million in cash.  The purchase, which is expected to close within the next 30 days, will provide the Company with a land-based, contained aquaculture system to grow AquAdvantage Salmon near major demand centers in the $2 billion U.S. Atlantic salmon market.  The United States currently imports over 92% of the farmed Atlantic salmon it consumes.  AquAdvantage Salmon will offer the opportunity for a viable domestic aquaculture industry while providing consumers a fresh and delicious product."
XON,XON:US,BBG000QL8VH9,Intrexon and Johnson Matthey Collaborate on Fermentative Production of Peptide-based Active Pharmaceutical Ingredients,2017-06-13 11:00:00 +0000,https://finance.yahoo.com/news/intrexon-johnson-matthey-collaborate-fermentative-110000579.html?.tsrc=rss,"Peptide-based APIs are used as highly effective treatments in numerous therapeutic classes.  ""Peptides are an important class of therapeutic agents and JM is pleased to be collaborating with the Intrexon team in using their innovative biologically-based technologies to access these technically challenging APIs,"" commented Robert MacLeod, Chief Executive of JM."
XON,XON:US,BBG000QL8VH9,Fibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized Scleroderma,2017-06-12 12:00:00 +0000,https://finance.yahoo.com/news/fibrocell-receives-rare-pediatric-disease-120000883.html?.tsrc=rss,"EXTON, Pa., June 12, 2017-- Fibrocell Science, Inc.,, a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa,2017-06-08 12:00:00 +0000,https://finance.yahoo.com/news/fibrocell-completes-dosing-first-cohort-120000941.html?.tsrc=rss,"EXTON, Pa., June 08, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces Positive Updated Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting,2017-06-05 18:15:00 +0000,https://finance.yahoo.com/news/ziopharm-oncology-announces-positive-updated-181500144.html?.tsrc=rss,Median Overall Survival in Expanded 20 mg Cohort Maintained at 12.5 Months and Continues to Compare Favorably to Historical Controls. Impact of Steroids and Circulating Immune Cells Correlate with Immune ...
XON,XON:US,BBG000QL8VH9,Four Stocks that Could be Affected by the Paris Agreement Decision,2017-06-02 15:49:00 +0000,http://finance.yahoo.com/r/b2f5173d-7719-3341-9574-ccf8a66f3352/four-stocks-could-be-affected-paris-agreement-decision-fslr-btu?partner=YahooSA&yptr=yahoo&.tsrc=rss,The decision to pull out of the Paris Agreement has muddled the outlook of many U.S. companies.
XON,XON:US,BBG000QL8VH9,ZIOPHARM to Present at the Jefferies 2017 Global Healthcare Conference,2017-06-02 11:00:00 +0000,https://finance.yahoo.com/news/ziopharm-present-jefferies-2017-global-110000405.html?.tsrc=rss,"BOSTON, June 02, 2017-- ZIOPHARM Oncology, Inc. today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference in New York on ..."
XON,XON:US,BBG000QL8VH9,Intrexon's Head of Environment Sector Joins Brazil Investment Forum to Discuss Importance of Vector Control and Economic Impact of Vector-borne Diseases,2017-05-31 12:00:00 +0000,https://finance.yahoo.com/news/intrexons-head-environment-sector-joins-120000233.html?.tsrc=rss,"Oxitec, a wholly-owned subsidiary of Intrexon Corporation (XON), announced that Lt. Gen. (Ret.) Tom Bostick, Ph.D., P.E., SVP, Head of Intrexon's Environment Sector, will speak at the Brazil Investment Forum in São Paulo today, Wednesday, May 31, 5pm (local time).  Dr. Bostick is in Brazil to discuss the importance of investments for vector control of disease-spreading insects."
XON,XON:US,BBG000QL8VH9,Intrexon's Head of Environment Sector Joins Brazil Investment Forum to Discuss Importance of Vector Control and Economic Impact of Vector-borne Diseases,2017-05-31 12:00:00 +0000,https://finance.yahoo.com/news/intrexons-head-environment-sector-joins-120000065.html?.tsrc=rss,"Oxitec, a wholly-owned subsidiary of Intrexon Corporation (XON), announced that Lt. Gen. (Ret.) Tom Bostick, Ph.D., P.E., SVP, Head of Intrexon's Environment Sector, will speak at the Brazil Investment Forum in São Paulo today, Wednesday, May 31, 5pm (local time).  Dr. Bostick is in Brazil to discuss the importance of investments for vector control of disease-spreading insects."
XON,XON:US,BBG000QL8VH9,Intrexon to Present at Upcoming Investor and Industry Conferences,2017-05-24 12:00:00 +0000,https://finance.yahoo.com/news/intrexon-present-upcoming-investor-industry-120000941.html?.tsrc=rss,"GERMANTOWN, Md., May 24, 2017 /PRNewswire/ --  Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec,2017-05-18 20:01:00 +0000,https://finance.yahoo.com/news/intrexon-appoints-dr-mark-carnegie-200100945.html?.tsrc=rss,"GERMANTOWN, Md., May 18, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the appointment of Mark Carnegie-Brown, Ph.D. as Chief Executive Officer of its wholly owned subsidiary Oxitec Ltd.  Dr. Carnegie-Brown succeeds Hadyn Parry, who has been appointed Vice President, Corporate Development Europe, the Middle East, and Africa (EMEA) for Intrexon to strengthen its management ranks abroad as it continues to expand its global presence.  Dr. Carnegie-Brown joins Oxitec with over 25 years leadership in the life science and health science industries."
XON,XON:US,BBG000QL8VH9,What You Missed in Intrexon's Quarterly Report,2017-05-18 15:16:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLWKksiWUls/what-you-missed-in-intrexons-quarterly-report-cm791220,Mr Market sent shares of engineered biology conglomerate Intrexon NYSE XON soaring after first quarter 2017 financial results were released There were encouraging signs for investors Operating loss shrank by one third compared to the year ago period marketable products appear
XON,XON:US,BBG000QL8VH9,What You Missed in Intrexon&apos;s Quarterly Report,2017-05-18 13:08:00 +0000,http://finance.yahoo.com/r/f0620742-9b55-3c7c-a5fb-cad98a4e07cc/what-you-missed-in-intrexons-quarterly-report.aspx?yptr=yahoo&.tsrc=rss,"The market cheered growing revenue, but the dependency on questionable sources deepened at the start of 2017."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma to be Presented at the 2017 ASCO Annual Meeting,2017-05-17 21:16:05 +0000,https://finance.yahoo.com/news/ziopharm-oncology-announces-results-ad-211605442.html?.tsrc=rss,"BOSTON, May 17, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter, dose-escalation ..."
XON,XON:US,BBG000QL8VH9,Fibrocell to Present at Inaugural Cell & Gene Exchange 2017,2017-05-17 12:00:00 +0000,https://finance.yahoo.com/news/fibrocell-present-inaugural-cell-gene-120000398.html?.tsrc=rss,"EXTON, Pa., May 17, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John ..."
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 10-May-17 8:30pm GMT,2017-05-17 09:10:51 +0000,https://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-035951286.html?.tsrc=rss,Q1 2017 Intrexon Corp Earnings Call
XON,XON:US,BBG000QL8VH9,How these two Tampa Bay companies got the financing to grow their technology,2017-05-16 16:18:35 +0000,http://finance.yahoo.com/r/16328911-2daf-3973-aaf9-c8cb3631d9a5/how-these-two-tampa-bay-companies-got-the.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Two of Tampa Bay’s smaller public companies have won a vote of confidence from investors.  Oragenics Inc. (NYSE MKT: OGEN), a biotech firm in Tampa, has commitments for $5.4 million in funding through a private stock deal and a loan.  MagneGas Corp. (MNGA), an alternative fuel firm in Largo, has an agreement with an institutional investor for $1 million in debt."
XON,XON:US,BBG000QL8VH9,"Notable Monday Option Activity: XON, REGN, NFLX",2017-05-15 21:16:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9mxJ11IzFQ/notable-monday-option-activity-xon-regn-nflx-cm789532,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Intrexon Corp Symbol XON where a total volume of 6 508 contracts has been traded thus far today a contract volume which is representative of approximately 650 800
XON,XON:US,BBG000QL8VH9,Intrexon Breaks Above 200-Day Moving Average - Bullish for XON,2017-05-15 17:17:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QG2pBWGl1_k/intrexon-breaks-above-200-day-moving-average-bullish-for-xon-cm789362,In trading on Monday shares of Intrexon Corp Symbol XON crossed above their 200 day moving average of 25 02 changing hands as high as 26 55 per share Intrexon Corp shares are currently trading up about 9 4 on the day The chart below shows the one year performance of XON shares versus
XON,XON:US,BBG000QL8VH9,Intrexon to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference,2017-05-15 12:00:00 +0000,https://finance.yahoo.com/news/intrexon-present-bank-america-merrill-120000310.html?.tsrc=rss,"GERMANTOWN, Md., May 15, 2017 /PRNewswire/ --  Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"Intrexon's First-Quarter 2017 Revenue Lacks Diversification, but Help Is On the Way",2017-05-12 20:31:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ysSfNJN1hfk/intrexons-first-quarter-2017-revenue-lacks-diversification-but-help-is-on-the-way-cm788779,As is usually the case engineered biology conglomerate Intrexon NYSE XON had a busy first three months of the year It listed 16 business developments at the top of its press release announcing first quarter 2017 financial results on par with past updates All but one were
XON,XON:US,BBG000QL8VH9,"Intrexon&apos;s First-Quarter 2017 Revenue Lacks Diversification, but Help Is On the Way",2017-05-12 20:18:00 +0000,http://finance.yahoo.com/r/f1bb7a98-b7ad-30c1-813a-63beada25008/intrexons-first-quarter-2017-revenue-lacks-diversi.aspx?yptr=yahoo&.tsrc=rss,"The same old risks plagued the company at the start of 2017, but meaningful product revenue is on the horizon."
XON,XON:US,BBG000QL8VH9,Ziopharm Prices Secondary Offering,2017-05-12 14:40:54 +0000,http://finance.yahoo.com/news/ziopharm-prices-secondary-offering-144054630.html?.tsrc=rss,Ziopharm Oncology saw its shares slide early on Friday after the company announced the pricing of its secondary offering.
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces Pricing of $50 Million Follow-On Offering of Common Stock,2017-05-12 13:20:00 +0000,http://finance.yahoo.com/news/ziopharm-oncology-announces-pricing-50-132000434.html?.tsrc=rss,"BOSTON, May 12, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it has priced an underwritten follow-on offering of 9,708,738 shares of ..."
XON,XON:US,BBG000QL8VH9,Today's Research Reports on Stocks to Watch: Himax Technologies and Intrexon Corporation,2017-05-12 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000842.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 12, 2017 / The rumor that Apple may have just placed a huge order with Taiwan-based Himax Technologies had shares soaring on Thursday, even though the company delivered ..."
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 10-May-17 8:30pm GMT,2017-05-12 00:16:05 +0000,http://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-035951286.html?.tsrc=rss,Q1 2017 Intrexon Corp Earnings Call
XON,XON:US,BBG000QL8VH9,"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN...",2017-05-11 22:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cjuSLLaUCqo/gainers--losers-of-may-11-sgmo-rnn-xon-mnkd-nvcn-20170511-01774,"Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN..."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q1 Loss Wider than Expected, Revenues Beat",2017-05-11 22:02:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X9aX9Ittzss/intrexon-xon-q1-loss-wider-than-expected-revenues-beat-cm788173,Intrexon Corporation XON reported loss per share of 26 cents in the first quarter of 2017 which was wider than the Zacks Consensus Estimate loss of 23 cents Total revenue came in at 53 7 million in the quarter up 23 7 year over year Reported revenues surpassed the
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q1 Loss Wider than Expected, Revenues Beat",2017-05-11 19:44:07 +0000,http://finance.yahoo.com/news/intrexon-xon-q1-loss-wider-194407695.html?.tsrc=rss,"Intrexon Corporation (XON) reported loss per share of 26 cents in the first quarter of 2017, which was wider than the Zacks Consensus Estimate loss of 23 cents."
XON,XON:US,BBG000QL8VH9,Why Intrexon Is Soaring Today,2017-05-11 18:03:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G7uQajrqtb8/why-intrexon-is-soaring-today-cm788026,What happened After Intrexon NYSE XON 160 a company focused on synthetic biology reported first quarter earnings its shares rose 18 as of 11 25 a m EDT on Thursday So what Here s a review of the headline numbers from the quarter Revenue grew 24
XON,XON:US,BBG000QL8VH9,Why Intrexon Is Soaring Today,2017-05-11 16:01:00 +0000,http://finance.yahoo.com/r/cfb2e724-f13d-3578-ae1f-e2cb1f45b34b/why-intrexon-is-soaring-today.aspx?yptr=yahoo&.tsrc=rss,Wall Street cheers the company&apos;s upbeat first-quarter earnings report.
XON,XON:US,BBG000QL8VH9,Intrexon reports 1Q loss,2017-05-10 20:24:24 +0000,http://finance.yahoo.com/news/intrexon-reports-1q-loss-202424556.html?.tsrc=rss,"The Germantown, Maryland-based company said it had a loss of 26 cents per share. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ..."
XON,XON:US,BBG000QL8VH9,Intrexon Announces First Quarter 2017 Financial Results,2017-05-10 20:05:00 +0000,http://finance.yahoo.com/news/intrexon-announces-first-quarter-2017-200500109.html?.tsrc=rss,"GERMANTOWN, Md., May 10, 2017 /PRNewswire/ --  Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"Earnings Reaction History: Intrexon Corporation, 28.6% Follow-Through Indicator, 6.6% Sensitive",2017-05-10 19:40:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E9XVHZmCmn0/earnings-reaction-history-intrexon-corporation-286-follow-through-indicator-66-sensitive-cm787452,Expected Earnings Release 05 10 2017 After hoursExpected Earnings Release 05 10 2017 After hours Avg Extended Hours Dollar Volume 2 082 418Avg Extended Hours Dollar Volume 2 082 418 Intrexon Corporation XON is due to issue its quarterly earnings report in the upcoming extended
XON,XON:US,BBG000QL8VH9,Intrexon and Darling to Build Commercial-scale Production of Insect-Based Advanced Feed Ingredients,2017-05-10 12:00:00 +0000,http://finance.yahoo.com/news/intrexon-darling-build-commercial-scale-120000369.html?.tsrc=rss,"DAVIS, Calif. and IRVING, Texas and YELLOW SPRINGS, Ohio, May 10, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Reports First Quarter 2017 Financial Results and Recent Operational Highlights,2017-05-10 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-reports-first-quarter-2017-120000452.html?.tsrc=rss,"EXTON, Pa., May 10, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial ..."
XON,XON:US,BBG000QL8VH9,"Medical Services Stock Q1 Earnings on May 10: CRL, XON, INCR",2017-05-09 16:05:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5I9A1ig4ucw/medical-services-stock-q1-earnings-on-may-10-crl-xon-incr-cm786532,With the earnings season drawing to a close and the majority of the bigwigs having reported results we can conclude that the earnings picture was positive As of May 5 412 S amp P 500 members that account for 85 7 of the index s total market capitalization reported results Earnings for
XON,XON:US,BBG000QL8VH9,"Medical Services Stock Q1 Earnings on May 10: CRL, XON, INCR",2017-05-09 13:58:01 +0000,http://finance.yahoo.com/news/medical-services-stock-q1-earnings-135801707.html?.tsrc=rss,Let&apos;s see what awaits these three medical services stocks that are slated to release their first-quarter 2017 results on May 10.
XON,XON:US,BBG000QL8VH9,Fibrocell and Intrexon Announce Two Oral Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy,2017-05-09 13:14:16 +0000,http://finance.yahoo.com/news/fibrocell-intrexon-announce-two-oral-131416495.html?.tsrc=rss,"EXTON, Pa. and GERMANTOWN, Md., May 09, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, and Intrexon ..."
XON,XON:US,BBG000QL8VH9,Huvepharma to Utilize Intrexon's Proprietary Fungal Expression Platform to Produce Key Animal Feed Enzyme,2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/huvepharma-utilize-intrexons-proprietary-fungal-120000478.html?.tsrc=rss,"SOFIA, Bulgaria and BUDAPEST, Hungary, May 9, 2017 /PRNewswire/ -- Huvepharma EOOD, a global pharmaceutical company with a focus on developing, manufacturing, and marketing human and animal health products, and Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced they have entered into a research collaboration agreement.  The collaboration represents the first commercial application of Intrexon's proprietary fungal expression platform to produce a new animal feed enzyme developed by Huvepharma."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : May 8, 2017",2017-05-08 13:11:55 +0000,http://finance.yahoo.com/r/bdc8e87d-2929-3206-89b0-56f54cacd1b9/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intrexon Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa,2017-05-08 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-announces-data-safety-monitoring-120000610.html?.tsrc=rss,"EXTON, Pa., May 08, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, announced today that the ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Announce First Quarter 2017 Financial Results on May 10th,2017-05-03 12:00:00 +0000,http://finance.yahoo.com/news/intrexon-announce-first-quarter-2017-120000233.html?.tsrc=rss,"GERMANTOWN, Md., May 3, 2017 /PRNewswire/ --   Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Wednesday, May 10, 2017 to Discuss First Quarter 2017 Financial Results and Recent Operational Highlights",2017-05-03 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-host-conference-call-webcast-120000202.html?.tsrc=rss,"EXTON, Pa., May 03, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will report financial results ..."
XON,XON:US,BBG000QL8VH9,Will Intrexon (XON) Pull Off a Surprise in Q1 Earnings?,2017-05-03 00:26:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yIntKmxVAIE/will-intrexon-xon-pull-off-a-surprise-in-q1-earnings-cm783134,Intrexon Corporation XON is expected to report first quarter 2017 results on May 9 The company missed expectations thrice in the four trailing quarters and matched estimates once with an average negative surprise of 12 37 Intrexon Corporation Price and EPS
XON,XON:US,BBG000QL8VH9,Will Intrexon (XON) Pull Off a Surprise in Q1 Earnings?,2017-05-02 22:38:10 +0000,http://finance.yahoo.com/news/intrexon-xon-pull-off-surprise-223810280.html?.tsrc=rss,Intrexon Corporation (XON) is expected to report first-quarter 2017 results on May 9.
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Announces FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia,2017-05-02 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-oncology-announces-fda-acceptance-110000994.html?.tsrc=rss,"BOSTON, May 02, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that an investigator-initiated Investigational New Drug application to the U.S. ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology Reports First Quarter 2017 Financial Results and Provides Update on Recent Activities,2017-05-01 20:05:00 +0000,http://finance.yahoo.com/news/ziopharm-oncology-reports-first-quarter-200500982.html?.tsrc=rss,"–Advancing Plans to Initiate Pivotal Study for Ad-RTS-hIL-12+ Veledimex for Treatment of Recurrent Brain Cancer–. -Company to Host Conference Call Today at 4:30 p.m. ET-. BOSTON, May 01, 2017-- ZIOPHARM ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. – Value Analysis (NYSE:XON) : April 27, 2017",2017-04-27 21:23:36 +0000,http://finance.yahoo.com/r/856c5b56-be24-375e-8b81-3bfcd044aa16/intrexon-corp-value-analysis-nysexon-april-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Intrexon Corp. a score of 56. Our analysis is based on comparing Intrexon Corp. with the following peers – ZIOPHARM Oncology, Inc., Eli Lilly and Company, Odyssey Marine Exploration, Inc., Thermo Fisher Scientific Inc., Fibrocell Science, Inc. and Synthetic Biologics, Inc. (ZIOP-US, LLY-US, OMEX-US, TMO-US, FCSC-US and ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,"Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors",2017-04-27 12:00:00 +0000,http://finance.yahoo.com/news/intrexon-appoints-vinita-gupta-leading-120000631.html?.tsrc=rss,"GERMANTOWN, Md., April 27, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the appointment of Vinita Gupta to its Board of Directors effective April 25, 2017.  Ms. Gupta is currently the Chief Executive Officer of Lupin Limited, a global pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs.  Ms. Gupta has served as CEO of India-based Lupin since 2012.  During her tenure as CEO, Lupin's revenue and global footprint has expanded significantly."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : April 26, 2017",2017-04-26 12:40:33 +0000,http://finance.yahoo.com/r/d68787e3-9eb7-3e08-b71e-00dfa36068db/intrexon-corp-breached-its-50-day-moving-average-in-a-bullish-manner-xon-us-april-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intrexon Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,"Commit To Purchase Intrexon Corp At $13, Earn 11.9% Using Options",2017-04-25 17:09:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fKRcJ0L67dU/commit-to-purchase-intrexon-corp-at-13-earn-119-using-options-cm778864,Investors eyeing a purchase of Intrexon Corp Symbol XON shares but tentative about paying the going market price of 21 09 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2019
XON,XON:US,BBG000QL8VH9,"ZIOPHARM Oncology to Host First-Quarter 2017 Financial Results and Corporate Update Conference Call on May 1, 2017 at 4:30 p.m. ET",2017-04-24 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-oncology-host-first-quarter-110000110.html?.tsrc=rss,"BOSTON, April 24, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will host a conference call and webcast slide presentation on Monday, ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Oncology to Present Updated Clinical Results of Gene Therapy Candidate Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting,2017-04-20 20:05:00 +0000,http://finance.yahoo.com/news/ziopharm-oncology-present-updated-clinical-200500310.html?.tsrc=rss,"BOSTON, April 20, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter, dose-escalation ..."
XON,XON:US,BBG000QL8VH9,Where Will Intrexon Be in 10 Years?,2017-04-18 17:05:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O3I2CT5xubc/where-will-intrexon-be-in-10-years-cm775317,The stock may be down 32 since its IPO but investors are still drawn to Intrexon NYSE XON for many reasons Whether it s the company s budding potential in healthcare applications or its technology platform for controlling mosquitoes and agricultural pests without spraying a
XON,XON:US,BBG000QL8VH9,Where Will Intrexon Be in 10 Years?,2017-04-18 15:20:00 +0000,http://finance.yahoo.com/r/95aa009f-d197-38d6-8a24-3b3f7d6b0a52/where-will-intrexon-be-in-10-years.aspx?yptr=yahoo&.tsrc=rss,The billionaire-led company&apos;s growth strategy promises that the stock&apos;s best days are ahead.
XON,XON:US,BBG000QL8VH9,GenVec investor alleges misleading financial disclosures ahead of Intrexon acquisition,2017-04-14 18:34:03 +0000,http://finance.yahoo.com/r/c2b6e05c-aa01-311d-abf9-586c51c176cc/genvec-investor-alleges-misleading-financial.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"An investor in Gaithersburg gene therapy company GenVec Inc. sued the company and its board this week following a deal inked earlier this year to be acquired by Germantown-based Intrexon Corp.  Intrexon (XON) and GenVec CEO Douglas Swirsky are also named in the suit.  The case, brought by investor James Hoose, alleges GenVec issued misleading disclosures in a Securities and Exchange Commission filing on March 17 to convince shareholders to vote in favor of the proposed deal."
XON,XON:US,BBG000QL8VH9,Fibrocell to Present at 7th Annual World Orphan Drug Congress USA 2017 and 5th Annual Cell & Gene Therapy Investor Day,2017-04-13 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-present-7th-annual-world-120000997.html?.tsrc=rss,"EXTON, Pa., April 13, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John ..."
XON,XON:US,BBG000QL8VH9,"The Municipality of Santiago de Cali, Colombia, and Oxitec Ltd. Announce Memorandum to Deploy Friendly™ Aedes",2017-04-10 11:00:00 +0000,http://finance.yahoo.com/news/municipality-santiago-cali-colombia-oxitec-110000437.html?.tsrc=rss,"The Municipality of Santiago de Cali, Colombia, and Oxitec Ltd. announced today a memorandum of understanding to deploy Friendly™ Aedes in the Comuna 16 region to help protect over 104,000 residents.  Friendly™ Aedes is an innovative approach to fight the Aedes aegypti mosquito that transmits Zika, dengue, chikungunya, Mayaro, and yellow fever."
XON,XON:US,BBG000QL8VH9,Intrexon (XON) Down 16.3% Since Earnings Report: Can It Rebound?,2017-04-03 13:39:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s1sOfdd1ZUo/intrexon-xon-down-163-since-earnings-report-can-it-rebound-cm768891,A month has gone by since the last earnings report for Intrexon Corporation XON Shares have lost about 16 3 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
XON,XON:US,BBG000QL8VH9,Intrexon (XON) Down 16.3% Since Earnings Report: Can It Rebound?,2017-04-03 11:30:11 +0000,http://finance.yahoo.com/news/intrexon-xon-down-16-3-113011409.html,Intrexon (XON) Down 16.3% Since Earnings Report: Can It Rebound?
XON,XON:US,BBG000QL8VH9,Intrexon (XON) Down 16.3% Since Earnings Report: Can It Rebound?,2017-04-03 11:30:11 +0000,http://finance.yahoo.com/news/intrexon-xon-down-16-3-113011409.html?.tsrc=rss,Intrexon (XON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
XON,XON:US,BBG000QL8VH9,"7:07 am Intrexon, ZIOPHARM (<a href=""/q?s=ziop"" name=""ziop"">ZIOP</a>), and Merck kGaA (<a href=""/q?s=mkgay"" name=""mkgay"">MKGAY</a>) update on the development of next-generation chimeric antigen receptor T cell therapy for cancer as",2017-04-03 11:07:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#xon,"7:07 am Intrexon, ZIOPHARM (<a href=""/q?s=ziop"" name=""ziop"">ZIOP</a>), and Merck kGaA (<a href=""/q?s=mkgay"" name=""mkgay"">MKGAY</a>) update on the development of next-generation chimeric antigen receptor T cell therapy for cancer as"
XON,XON:US,BBG000QL8VH9,"Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered by Membrane-Bound IL-15 Under RheoSwitch Therapeutic System® Control",2017-04-03 11:00:00 +0000,http://finance.yahoo.com/news/intrexon-ziopharm-merck-kgaa-darmstadt-110000121.html,"[GlobeNewswire] - GERMANTOWN, Md. and BOSTON, April 03, 2017-- Intrexon Corporation, a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ZIOPHARM Oncology, ..."
XON,XON:US,BBG000QL8VH9,"Intrexon, ZIOPHARM and Merck KGaA, Darmstadt, Germany Advancing Next-Generation Non-Viral CAR-T Platform Empowered by Membrane-Bound IL-15 Under RheoSwitch Therapeutic System® Control",2017-04-03 11:00:00 +0000,http://finance.yahoo.com/news/intrexon-ziopharm-merck-kgaa-darmstadt-110000121.html?.tsrc=rss,"GERMANTOWN, Md. and BOSTON, April 03, 2017-- Intrexon Corporation, a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ZIOPHARM Oncology, ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2017-03-31 20:40:04 +0000,http://biz.yahoo.com/e/170331/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
XON,XON:US,BBG000QL8VH9,"Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project",2017-03-30 11:26:00 +0000,http://finance.yahoo.com/news/oxitecs-friendly-aedes-achieves-81-112600345.html?.tsrc=rss,"Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project"
XON,XON:US,BBG000QL8VH9,"Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project",2017-03-30 11:26:00 +0000,http://finance.yahoo.com/news/oxitecs-friendly-aedes-achieves-81-112600345.html,"[CNW Group] - Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project"
XON,XON:US,BBG000QL8VH9,"Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project",2017-03-30 11:00:00 +0000,http://finance.yahoo.com/news/oxitecs-friendly-aedes-achieves-81-110000170.html,"[PR Newswire] - Oxitec and Piracicaba City Hall announced today new results from the Friendly™ Aedes project in the CECAP/Eldorado district and the first results in the São Judas neighborhood in the city's central region. In CECAP/Eldorado, Friendly™ Aedes has once again achieved high levels of 81% suppression of wild Aedes aegypti larvae in the treated area compared to the non-treated area. This is the second consecutive year the level of suppression has exceeded 80%. Importantly, the number of Friendly™ Aedes released in 2016 to maintain this high level of suppression was 59% below the year prior, illustrating the strength and durability of Oxitec's solution."
XON,XON:US,BBG000QL8VH9,Cramer's lightning round: Stick with this 'terrific' defense play,2017-03-28 22:51:16 +0000,http://www.cnbc.com/id/104369203?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104369203,Cramer's lightning round: Stick with this 'terrific' defense play
XON,XON:US,BBG000QL8VH9,Here's Why Ziopharm Rose as Much as 15.8% Today,2017-03-27 22:59:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XT_-Vd5G-JQ/heres-why-ziopharm-rose-as-much-as-158-today-cm766248,What happened Shares of clinical stage biopharma Ziopharm NASDAQ ZIOP rose nearly 16 Monday after announcing that it received positive guidance from the U S Food and Drug Administration regarding plans to move forward with its lead gene therapy candidate The treatment
XON,XON:US,BBG000QL8VH9,ZIOPHARM Announces Successful End-of-Phase 2 Meeting with FDA for Ad-RTS-hIL-12 Gene Therapy in Recurrent Glioblastoma,2017-03-27 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-announces-successful-end-phase-120000460.html?.tsrc=rss,"BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the receipt of positive guidance from an End-of-Phase 2 meeting with the U.S. ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Announces Successful End-of-Phase 2 Meeting with FDA for Ad-RTS-hIL-12 Gene Therapy in Recurrent Glioblastoma,2017-03-27 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-announces-successful-end-phase-120000460.html,"[GlobeNewswire] - BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the receipt of positive guidance from an End-of-Phase 2 meeting with the U.S. ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications,2017-03-27 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-appoints-amy-trevvett-vice-110000454.html,"[GlobeNewswire] - BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the appointment of Amy Trevvett as Vice President of Investor Relations and ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications,2017-03-27 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-appoints-amy-trevvett-vice-110000454.html?.tsrc=rss,"BOSTON, March 27, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the appointment of Amy Trevvett as Vice President of Investor Relations and ..."
XON,XON:US,BBG000QL8VH9,3 Stocks That Are Overvalued,2017-03-22 20:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dtNtdyK1OHo/3-stocks-that-are-overvalued-cm764344,Casey s General Stores NASDAQ CASY Zoe s Kitchen NYSE ZOES and Intrexon Corp NYSE XON are very different businesses in very different industries but they do share one thing in common All three appear to be overvalued to our Motley Fool contributors Could
XON,XON:US,BBG000QL8VH9,3 Stocks That Are Overvalued,2017-03-22 19:42:00 +0000,http://finance.yahoo.com/r/05bbcef5-37fa-36e0-abd0-b2771c1671cb/3-stocks-that-are-overvalued.aspx?yptr=yahoo&.tsrc=rss,"Motley Fool contributors have considered the obstacles facing Casey's General Stores, Zoe's Kitchen, and Intrexon Corp. and concluded their share prices have become too rich."
XON,XON:US,BBG000QL8VH9,3 Stocks That Are Overvalued,2017-03-22 19:42:00 +0000,https://www.fool.com/investing/2017/03/22/3-stocks-that-are-overvalued.aspx,3 Stocks That Are Overvalued
XON,XON:US,BBG000QL8VH9,Jorge Espanha Appointed General Manager of Oxitec do Brasil,2017-03-17 11:00:00 +0000,http://finance.yahoo.com/news/jorge-espanha-appointed-general-manager-110000441.html?.tsrc=rss,"Oxitec today announced the appointment of Jorge Espanha as General Manager of Oxitec's Brazilian subsidiary, Oxitec do Brasil.  Mr. Espanha will oversee Oxitec's programs in Brazil to deploy the environmentally-friendly vector control solution, Friendly™ Aedes.  Hadyn Parry, Chief Executive Officer at Oxitec, said, ""We are delighted to welcome Jorge to the Oxitec team."
XON,XON:US,BBG000QL8VH9,Jorge Espanha Appointed General Manager of Oxitec do Brasil,2017-03-17 11:00:00 +0000,http://finance.yahoo.com/news/jorge-espanha-appointed-general-manager-110000441.html,"[PR Newswire] - Oxitec today announced the appointment of Jorge Espanha as General Manager of Oxitec's Brazilian subsidiary, Oxitec do Brasil. Mr. Espanha will oversee Oxitec's programs in Brazil to deploy the environmentally-friendly vector control solution, Friendly™ Aedes. Hadyn Parry, Chief Executive Officer at Oxitec, said, ""We are delighted to welcome Jorge to the Oxitec team."
XON,XON:US,BBG000QL8VH9,"AquaBounty Technologies, Inc. Results for the year ended December 31, 2016",2017-03-16 07:00:00 +0000,http://finance.yahoo.com/news/aquabounty-technologies-inc-results-ended-070000942.html?.tsrc=rss,"MAYNARD, Mass., March 16, 2017 /PRNewswire/ -- AquaBounty Technologies, Inc. (NASDAQ: AQB; AIM: ABTU) (""AquaBounty"" or the ""Company""), a biotechnology company focused on enhancing productivity ..."
XON,XON:US,BBG000QL8VH9,"AquaBounty Technologies, Inc. Results for the year ended December 31, 2016",2017-03-16 07:00:00 +0000,http://finance.yahoo.com/news/aquabounty-technologies-inc-results-ended-070000942.html,"[PR Newswire] - MAYNARD, Mass., March 16, 2017 /PRNewswire/ -- AquaBounty Technologies, Inc. (NASDAQ: AQB; AIM: ABTU) (""AquaBounty"" or the ""Company""), a biotechnology company focused on enhancing productivity ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : March 14, 2017",2017-03-14 12:47:49 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-march-14-2017/,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : March 14, 2017"
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : March 14, 2017",2017-03-14 12:47:49 +0000,http://finance.yahoo.com/r/896b91c2-b8b9-36c0-9358-c15cd2aee602/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-march-14-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Intrexon Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Intrexon executive out less than a year after joining the company,2017-03-13 19:45:02 +0000,http://www.bizjournals.com/washington/news/2017/03/13/intrexons-geno-germano-out-less-than-a-year-after.html?ana=yahoo,Intrexon executive out less than a year after joining the company
XON,XON:US,BBG000QL8VH9,Intrexon executive out less than a year after joining the company,2017-03-13 19:45:02 +0000,http://finance.yahoo.com/r/d79debb8-7aed-315e-8cc3-bb9df2ede665/intrexons-geno-germano-out-less-than-a-year-after.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Germantown-based Intrexon Corp. brought on Pfizer Inc. (PFE) alum Geno Germano as its president last May to oversee its health commercialization efforts .  Germantown-based Intrexon (XON) announced Friday it will split off all its health-related research and partnerships — including its 75 percent stake in Xogenex, a company that’s developing a gene-based treatment for cardiac disease — into a new subsidiary called Precigen Inc. It is looking for a new executive to lead that venture.  In a statement, Germano said he was returning to his roots in the drug industry."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat",2017-03-10 21:34:07 +0000,http://biz.yahoo.com/e/170310/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat"
XON,XON:US,BBG000QL8VH9,"Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets",2017-03-10 21:15:00 +0000,http://finance.yahoo.com/news/intrexon-creates-precigen-inc-accelerates-211500062.html,"[PR Newswire] - GERMANTOWN, Md., March 10, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the formation of Precigen, Inc., a wholly-owned subsidiary of the Company as part of an ongoing evaluation of structural alternatives concerning its business in healthcare. Intrexon currently intends to consolidate all health-related assets under this new corporate entity as it considers potential strategic options to enhance shareholder value. ""While we have been reviewing potential options for over a year, as our collaborators increasingly begin to move into the clinic, it is apparent that our collection of health assets may be overshadowed by the breadth and complexity of the opportunities the engineering of biology has afforded us. We are therefore taking this structural action now to better position us for strategic decisions regarding our health business moving forward,"" said Randal J Kirk, Intrexon's Chairman and CEO."
XON,XON:US,BBG000QL8VH9,"Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets",2017-03-10 21:15:00 +0000,http://finance.yahoo.com/news/intrexon-creates-precigen-inc-accelerates-211500062.html?.tsrc=rss,"GERMANTOWN, Md., March 10, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the formation of Precigen, Inc., a wholly-owned subsidiary of the Company as part of an ongoing evaluation of structural alternatives concerning its business in healthcare.  Intrexon currently intends to consolidate all health-related assets under this new corporate entity as it considers potential strategic options to enhance shareholder value.  ""While we have been reviewing potential options for over a year, as our collaborators increasingly begin to move into the clinic, it is apparent that our collection of health assets may be overshadowed by the breadth and complexity of the opportunities the engineering of biology has afforded us.  We are therefore taking this structural action now to better position us for strategic decisions regarding our health business moving forward,"" said Randal J Kirk, Intrexon's Chairman and CEO."
XON,XON:US,BBG000QL8VH9,Fibrocell Reports 2016 Financial Results and Recent Operational Highlights,2017-03-09 13:00:00 +0000,http://finance.yahoo.com/news/fibrocell-reports-2016-financial-results-130000738.html,"[GlobeNewswire] - EXTON, Pa., March 09, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Reports 2016 Financial Results and Recent Operational Highlights,2017-03-09 13:00:00 +0000,http://finance.yahoo.com/news/fibrocell-reports-2016-financial-results-130000738.html?.tsrc=rss,"EXTON, Pa., March 09, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today reported financial ..."
XON,XON:US,BBG000QL8VH9,Can Intrexon Regain Its Mojo?,2017-03-08 17:16:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DvpzDrAfxWI/can-intrexon-regain-its-mojo-cm757959,Engineered biology conglomerate Intrexon NYSE XON has a lot to offer investors Anyone in doubt only needs to open the recent press release announcing full year 2016 financial results which listed 20 business highlights and recent developments before going into financial
XON,XON:US,BBG000QL8VH9,Can Intrexon Regain Its Mojo?,2017-03-08 15:09:00 +0000,http://www.fool.com/investing/2017/03/08/can-intrexon-regain-its-mojo.aspx,Can Intrexon Regain Its Mojo?
XON,XON:US,BBG000QL8VH9,Can Intrexon Regain Its Mojo?,2017-03-08 15:09:00 +0000,http://finance.yahoo.com/r/3cfa8286-3d67-3bd6-a7c3-df3ab439014d/can-intrexon-regain-its-mojo.aspx?yptr=yahoo&.tsrc=rss,The high-growth biotech stock is down 37.5% in the last year.
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Thursday, March 9, 2017 to Discuss 2016 Financial Results and Recent Operational Highlights",2017-03-07 22:15:00 +0000,http://finance.yahoo.com/news/fibrocell-host-conference-call-webcast-221500682.html?.tsrc=rss,"EXTON, Pa., March 07, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will report financial results ..."
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Thursday, March 9, 2017 to Discuss 2016 Financial Results and Recent Operational Highlights",2017-03-07 22:15:00 +0000,http://finance.yahoo.com/news/fibrocell-host-conference-call-webcast-221500682.html,"[GlobeNewswire] - EXTON, Pa., March 07, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will report financial results ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million,2017-03-07 21:54:52 +0000,http://finance.yahoo.com/news/fibrocell-announces-convertible-preferred-stock-215452384.html,"[GlobeNewswire] - EXTON, Pa., March 07, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that it ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million,2017-03-07 21:54:52 +0000,http://finance.yahoo.com/news/fibrocell-announces-convertible-preferred-stock-215452384.html?.tsrc=rss,"EXTON, Pa., March 07, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that it ..."
XON,XON:US,BBG000QL8VH9,INTREXON CORP Financials,2017-03-07 18:04:18 +0000,http://finance.yahoo.com/q/is?s=xon,INTREXON CORP Financials
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017",2017-03-07 16:32:32 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-xon-us-earnings-analysis-q4-2016-by-the-numbers-march-7-2017/,"Intrexon Corp. :XON-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017"
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017",2017-03-07 16:32:32 +0000,http://finance.yahoo.com/r/2195b631-c6c5-3e5e-a1d4-52f5eeee4261/intrexon-corp-xon-us-earnings-analysis-q4-2016-by-the-numbers-march-7-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Intrexon Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Intrexon Corp. – ZIOPHARM Oncology, Inc., Eli Lilly and Company and Thermo Fisher Scientific Inc. (ZIOP-US, LLY-US and TMO-US) that have also reported for this period. Highlights Summary numbers: ... Read more    
<b>(Read more...)</b>"
XON,XON:US,BBG000QL8VH9,Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco,2017-03-07 13:07:00 +0000,http://finance.yahoo.com/r/c20378b5-9d32-3f42-b6ad-1f7c1e4e496b/shell-deal-hands-biggest-u-s-oil-refinery-to-saudi-aramco.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Saudi Aramco will assume control of the biggest oil refinery in the U.S. after a $2.2 billion deal with Shell that exits a joint venture in Port Arthur, Texas."
XON,XON:US,BBG000QL8VH9,Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco,2017-03-07 13:07:00 +0000,https://www.thestreet.com/story/14029565/1/shell-deal-hands-biggest-u-s-oil-refinery-to-saudi-aramco.html?puc=yahoo&cm_ven=YAHOO,Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco
XON,XON:US,BBG000QL8VH9,"Andy Bass to Lead Biological & Popular Culture, Intrexon's Consumer Sector",2017-03-06 14:00:00 +0000,http://finance.yahoo.com/news/andy-bass-lead-biological-popular-140000122.html,"[PR Newswire] - SAN DIEGO, March 6, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the appointment of Andy Bass as Senior Vice President, Consumer Sector, which will henceforth do business as BioPop. Andy will lead the design and commercialization of new biologically-based products and applications across consumer markets using Intrexon's powerful platforms and expertise for engineering biology. Andy brings extensive experience in life sciences and consumer product development to Intrexon. Most recently he co-founded and served as Chief Executive Officer of Biological & Popular Culture, Inc. (BioPop), now a wholly owned subsidiary of Intrexon and a consumer biotechnology company selling products in more than 20 countries."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q4 Loss Wider than Expected, Revenues Lag",2017-03-03 21:12:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pBepa6ur4wM/intrexon-xon-q4-loss-wider-than-expected-revenues-lag-cm756148,Shares of Intrexon Corporation XON rose more than 8 on Mar 2 since it announced its fourth quarter 2016 results However on a year to date basis shares of the company have lost 3 1 while the Zacks classified Medical Medical Services industry gained 7 5 Intrexon reported
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Q4 Loss Wider than Expected, Revenues Lag",2017-03-03 19:25:07 +0000,http://finance.yahoo.com/news/intrexon-xon-q4-loss-wider-192507925.html,"Intrexon (XON) Q4 Loss Wider than Expected, Revenues Lag"
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : March 3, 2017",2017-03-03 12:24:47 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bullish-manner-xon-us-march-3-2017/,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : March 3, 2017"
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 1-Mar-17 10:30pm GMT,2017-03-02 07:24:31 +0000,http://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-072431618.html,Edited Transcript of XON earnings conference call or presentation 1-Mar-17 10:30pm GMT
XON,XON:US,BBG000QL8VH9,Intrexon reports 4Q loss,2017-03-01 23:21:11 +0000,http://sg.finance.yahoo.com/news/intrexon-reports-4q-loss-232111461.html,Intrexon reports 4Q loss
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial",2017-03-01 22:17:24 +0000,http://biz.yahoo.com/e/170301/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial"
XON,XON:US,BBG000QL8VH9,Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results,2017-03-01 22:10:00 +0000,http://finance.yahoo.com/news/intrexon-announces-fourth-quarter-full-221000061.html,"[PR Newswire] - GERMANTOWN, Md., March 1, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"After-Hours Earnings Report for March 1, 2017 :  AVGO, MNST, OPK, VGR, XON, FSIC, JUNO, ICUI, NKTR, SQM, FGEN, GKOS",2017-03-01 20:11:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ICffZYcD1Ho/after-hours-earnings-report-for-march-1-2017-avgo-mnst-opk-vgr-xon-fsic-juno-icui-nktr-sqm-fgen-gkos-cm754988,The following companies are expected to report earnings after hours on 03 01 2017 Visit our Earnings Calendar for a full list of expected earnings releases Broadcom Limited AVGO is reporting for the quarter ending January 31 2017 The electric
XON,XON:US,BBG000QL8VH9,Q4 2016 Intrexon Corp Earnings Release - After Market Close,2017-03-01 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170301.html?t=xon,Q4 2016 Intrexon Corp Earnings Release - After Market Close
XON,XON:US,BBG000QL8VH9,"Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More",2017-02-28 12:17:12 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-lineup-121712792.html,"Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More"
XON,XON:US,BBG000QL8VH9,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?,2017-02-28 01:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Y83BE138cQ/intrexon-xon-will-the-stock-pull-a-surprise-in-q4-earnings-cm753922,Intrexon Corporation XON is scheduled to report fourth quarter 2016 results on Mar 1 after the market closes Intrexon sshare price has decreased 9 9 year to date while the Zacks classified Medical Medical Services industry gained 4 3 In the last reported quarter the
XON,XON:US,BBG000QL8VH9,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?,2017-02-27 23:20:11 +0000,http://finance.yahoo.com/news/intrexon-xon-stock-pull-surprise-232011909.html,Intrexon (XON): Will the Stock Pull a Surprise in Q4 Earnings?
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa,2017-02-23 13:00:00 +0000,http://finance.yahoo.com/news/fibrocell-announces-dosing-first-patient-130000556.html,"[GlobeNewswire] - EXTON, Pa., Feb. 23, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st,2017-02-22 13:00:00 +0000,http://finance.yahoo.com/news/intrexon-announce-fourth-quarter-full-130000356.html,"[PR Newswire] - GERMANTOWN, Md., Feb. 22, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,Investors Are Betting Big Against Intrexon -- Here's Why They're Right,2017-02-17 22:07:44 +0000,http://www.fool.com/investing/2017/02/17/investors-are-betting-big-against-intrexon-why-the.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Investors Are Betting Big Against Intrexon -- Here's Why They're Right
XON,XON:US,BBG000QL8VH9,Investors Are Betting Big Against Intrexon -- Here's Why They're Right,2017-02-17 15:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VNSQtH-l7fg/investors-are-betting-big-against-intrexon-heres-why-theyre-right-cm749572,Engineered biology conglomerate Intrexon NYSE XON has perfected the storytelling aspect of being a publicly traded company that wields a potentially transformative portfolio of technologies Need more information on genetically engineered mosquitoes that could control disease
XON,XON:US,BBG000QL8VH9,ZIOPHARM Reports Fourth-Quarter 2016 Financial Results and Provides Update on Recent Activities,2017-02-16 21:05:00 +0000,http://finance.yahoo.com/news/ziopharm-reports-fourth-quarter-2016-210500041.html,"[GlobeNewswire] - -Company to Webcast Corporate Update Thursday, February 23, at the 2017 RBC Global Healthcare Conference-. BOSTON, Feb. 16, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, ..."
XON,XON:US,BBG000QL8VH9,GMOs and engineered biology,2017-02-16 12:35:00 +0000,http://finance.yahoo.com/video/gmos-engineered-biology-123500916.html,GMOs and engineered biology
XON,XON:US,BBG000QL8VH9,"Gainers & Losers Of The Day: ZSAN, EVOK, ARDX, EARS, NEOT...",2017-02-15 20:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/co65V0oScHs/gainers--losers-of-the-day-zsan-evok-ardx-ears-neot-20170215-01649,"Gainers & Losers Of The Day: ZSAN, EVOK, ARDX, EARS, NEOT..."
XON,XON:US,BBG000QL8VH9,"Lt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National Academy of Engineering",2017-02-13 13:00:00 +0000,http://finance.yahoo.com/news/lt-gen-ret-thomas-p-130000169.html,"[PR Newswire] - GERMANTOWN, Md., Feb. 13, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Lt. Gen. (Ret.) Thomas P. Bostick Ph.D., P.E., Senior Vice President and Head of Intrexon's Environment Sector, has been elected to the National Academy of Engineering (NAE). Dr. Bostick was elected for development of new approaches to hurricane protection and for his leadership of the U.S. Army Corps of Engineers (USACE) and many other significant positions throughout his military career."
XON,XON:US,BBG000QL8VH9,"Gainers & Losers Of The Day: PULM, AQB, GALE, PETX, KTOV...",2017-02-06 20:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0AU-NLkFUkg/gainers--losers-of-the-day-pulm-aqb-gale-petx-ktov-20170206-01406,"Gainers & Losers Of The Day: PULM, AQB, GALE, PETX, KTOV..."
XON,XON:US,BBG000QL8VH9,Did a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January?,2017-02-06 18:18:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zv3x0ypJHUk/did-a-case-of-buyers-remorse-send-intrexon-corporation-down-13-in-january-cm743712,What happened Shares of Intrexon NYSE XON a life sciences company focused on the development of proprietary technologies designed to regulate genes with the purpose of treating serious diseases fell 13 during the month of January according to data from S amp P
XON,XON:US,BBG000QL8VH9,Did a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January?,2017-02-06 16:51:06 +0000,http://www.fool.com/investing/2017/02/06/did-a-case-of-buyers-remorse-send-intrexon-corpora.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Did a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January?
XON,XON:US,BBG000QL8VH9,"Why Bill Miller Likes Apple, Intrexon, Bets on Fiat Chrysler and Considers OneMain Holdings the Perfect “Trump Stock”",2017-02-06 16:28:24 +0000,http://www.insidermonkey.com/blog/why-bill-miller-likes-apple-intrexon-bets-on-fiat-chrysler-and-considers-onemain-holdings-the-perfect-trump-stock-532118/,"Why Bill Miller Likes Apple, Intrexon, Bets on Fiat Chrysler and Considers OneMain Holdings the Perfect “Trump Stock”"
XON,XON:US,BBG000QL8VH9,Bill Miller is bullish about this Maryland biotech that makes non-browning apples,2017-02-02 21:50:08 +0000,http://www.bizjournals.com/baltimore/news/2017/02/02/bill-miller-is-bullish-about-this-maryland-biotech.html?ana=yahoo,Bill Miller is bullish about this Maryland biotech that makes non-browning apples
XON,XON:US,BBG000QL8VH9,"GENVEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenVec, Inc.",2017-02-02 16:41:00 +0000,http://finance.yahoo.com/news/genvec-investor-alert-former-attorney-164100184.html,"[PR Newswire] - NEW ORLEANS, Feb. 2, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (""KSF"") are investigating the proposed sale ..."
XON,XON:US,BBG000QL8VH9,Bill Miller: Apple's cheap but this 'arctic apple' stock ...,2017-02-02 12:53:00 +0000,http://finance.yahoo.com/video/bill-miller-apples-cheap-arctic-125300661.html,Bill Miller: Apple's cheap but this 'arctic apple' stock ...
XON,XON:US,BBG000QL8VH9,3 Strong Reasons to Sell Intrexon,2017-01-31 15:33:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hnrzm6CTdhY/3-strong-reasons-to-sell-intrexon-cm740721,Image source Getty Images Engineered biology conglomerate Intrexon NYSE XON is mired in a rut of setting new 52 week lows The stock didn t do anything particularly special in 2016 and is now down 24 since its IPO in mid 2013 Despite the rough life in the public markets
XON,XON:US,BBG000QL8VH9,3 Strong Reasons to Sell Intrexon,2017-01-31 14:14:42 +0000,http://www.fool.com/investing/2017/01/31/3-strong-reasons-to-sell-intrexon.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Strong Reasons to Sell Intrexon
XON,XON:US,BBG000QL8VH9,ZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing “Point-of-Care” Approach,2017-01-31 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-utilizing-non-viral-sleeping-120000313.html,[GlobeNewswire] - –First Patient Treated with Non-viral Sleeping Beauty Modified CAR-T Cells Produced in 2 Weeks. –Anticipate Phase 1 Clinical Trial Launch in 2017 with Administration of Sleeping Beauty CAR-T Cells Produced ...
XON,XON:US,BBG000QL8VH9,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of GenVec, Inc. to Intrexon Corporation is Fair to Shareholders - GNVC",2017-01-26 20:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-201000212.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 26, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased GenVec, Inc. (NASDAQ: GNVC) stock prior to January ..."
XON,XON:US,BBG000QL8VH9,Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease,2017-01-26 13:00:00 +0000,http://finance.yahoo.com/news/exemplar-genetics-awarded-subcontract-advance-130000388.html,"[PR Newswire] - SIOUX CENTER, Iowa, Jan. 26, 2017 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (XON) committed to enabling the study of life-threatening human diseases, has been awarded a subcontract to create genetically engineered miniswine models of sickle cell disease as part of a national resource that could lead to new treatments for the disorder. The subcontract is with Leidos Biomedical Research, Inc., prime contractor for the Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute, part of the National Institutes of Health (NIH)."
XON,XON:US,BBG000QL8VH9,Intrexon To Buy GenVec In Stock Deal For $7/Shr,2017-01-25 15:08:00 +0000,http://www.investopedia.com/news/intrexon-buy-genvec-7-share-xon-gnvc/?partner=YahooSA,Intrexon To Buy GenVec In Stock Deal For $7/Shr
XON,XON:US,BBG000QL8VH9,"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA...",2017-01-25 00:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7IkfIqdddxg/gainers--losers-of-the-day-gnvc-nviv-clrb-aqb-bioa-20170125-00009,"Gainers & Losers Of The Day: GNVC, NVIV, CLRB. AQB, BIOA..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-01-24 21:08:34 +0000,http://biz.yahoo.com/e/170124/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
XON,XON:US,BBG000QL8VH9,Biogen Inc (BIIB) Stock Enters Uncharted Waters,2017-01-24 20:31:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lAcVpFyXV1c/biogen-inc-biib-stock-enters-uncharted-waters-cm737564,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Biogen Inc NASDAQ BIIB reminds me of a company making big computers in 1977 Source Biogen via YouTube The industry is about to be transformed completely but most people are focused only
XON,XON:US,BBG000QL8VH9,Intrexon to acquire fellow Md. biotech,2017-01-24 18:54:53 +0000,http://www.bizjournals.com/washington/news/2017/01/24/intrexon-to-acquire-fellow-md-biotech.html?ana=yahoo,Intrexon to acquire fellow Md. biotech
XON,XON:US,BBG000QL8VH9,Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform,2017-01-24 14:00:00 +0000,http://finance.yahoo.com/news/intrexon-acquire-genvec-expand-industry-140000103.html,"[PR Newswire] - GERMANTOWN, Md., and GAITHERSBURG, Md., Jan. 24, 2017 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into a definitive agreement to acquire GenVec, Inc. Intrexon intends to integrate and expand upon GenVec's expertise in adenoviral vectors and cGMP drug product manufacturing to enhance its broad gene transfer capabilities that encompass multiple viral and non-viral platforms. Notably, the combined technologies have the potential to yield the next generation of adenoviral (AdV) delivery through the creation of a scalable manufacturing platform utilizing helper-dependent adenovirus with significantly higher payload capacity of >30kb, as compared to current viral delivery methods ranging from 4.5kb – 9kb."
XON,XON:US,BBG000QL8VH9,Insiders Now Seeing Red With XON At New 52-Week Low,2017-01-23 19:31:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/81et9TpsobU/insiders-now-seeing-red-with-xon-at-new-52-week-low-cm736915,In trading on Monday shares of Intrexon Corp Symbol XON touched a new 52 week low of 22 08 share That s a 17 77 share price drop or 44 59 decline from the 52 week high of 39 85 set back on 03 07 2016 Large percentage drops always require that the stock post even larger percentage
XON,XON:US,BBG000QL8VH9,Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India,2017-01-23 12:00:00 +0000,http://finance.yahoo.com/news/oxitec-gbit-announce-launch-friendly-120000805.html,"[PR Newswire] - Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec announced today the launch of the Friendly™ Aedes project in Dawalwadi, India. Outdoor caged trials of Oxitec's Friendly™ Aedes mosquito have been initiated to demonstrate the efficacy of the Friendly™ mosquitoes in suppressing the local Aedes aegypti population."
XON,XON:US,BBG000QL8VH9,AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon,2017-01-19 12:00:00 +0000,http://finance.yahoo.com/news/aquabounty-announces-completion-nasdaq-listing-120000697.html,"[PR Newswire] - NASDAQ: AQB), a biotechnology company focused on enhancing productivity in aquaculture and a majority-owned subsidiary of Intrexon Corporation (XON), announces that it has completed the listing of its common shares on the NASDAQ Stock Market and finalized the equity subscription from Intrexon. ""AquaBounty's listing on NASDAQ represents an important milestone for the Company that will broaden our exposure to the U.S. markets as we advance plans for commercial production of our pioneering, environmentally responsible approach to fish farming,"" said Ronald L. Stotish, Ph.D., Chief Executive Officer of AquaBounty."
XON,XON:US,BBG000QL8VH9,"Intrexon Announces ""When-Issued"" Trading of AquaBounty Technologies In Connection With Special Stock Dividend of Shares",2017-01-12 13:00:00 +0000,http://finance.yahoo.com/news/intrexon-announces-issued-trading-aquabounty-130000436.html,"[PR Newswire] - GERMANTOWN, Md., Jan. 12, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON)(""Intrexon"" or the ""Company""), a leader in the engineering and industrialization of biology to improve ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2017-01-11 16:58:16 +0000,http://biz.yahoo.com/e/170111/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
XON,XON:US,BBG000QL8VH9,ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens,2017-01-10 13:00:00 +0000,http://finance.yahoo.com/news/ziopharm-intrexon-announce-cooperative-research-130000460.html,"[PR Newswire] - BOSTON and GERMANTOWN, Md., Jan. 10, 2017 /PRNewswire/ -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, and Intrexon Corporation (NYSE:XON), a leader ..."
XON,XON:US,BBG000QL8VH9,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation",2017-01-09 16:40:31 +0000,http://finance.yahoo.com/news/exclusive-ziopharm-ceo-talks-partnerships-164031161.html,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation"
XON,XON:US,BBG000QL8VH9,INTREXON CORP Financials,2017-01-07 18:04:05 +0000,http://finance.yahoo.com/q/is?s=xon&annual,INTREXON CORP Financials
XON,XON:US,BBG000QL8VH9,Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa,2017-01-05 13:00:00 +0000,http://finance.yahoo.com/news/fibrocell-announces-fda-fast-track-130000599.html,"[GlobeNewswire] - EXTON, Pa., Jan. 05, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the ..."
XON,XON:US,BBG000QL8VH9,"January 4, 2017 – Reverse share split further update (PDF)",2017-01-04 14:13:07 +0000,http://www.publicnow.com/view/9007596FB5DC39B9B4219B83EAB4C323FCB18B5D,"[at noodls] - 4 January 2017 AquaBounty Technologies Inc. (""AquaBounty"" or the ""Company"") Reverse Share Split Further Update AquaBounty Technologies, Inc. (AIM: ABTU), a biotechnology company focused ..."
XON,XON:US,BBG000QL8VH9,Oragenics Shareholder Update,2017-01-04 12:45:00 +0000,http://finance.yahoo.com/news/oragenics-shareholder-124500484.html,"[Business Wire] - Oragenics, Inc. , a clinical stage biotechnology company advancing lantibiotics to treat serious bacterial infections and biotherapeutics to treat oral mucositis , today issued a shareholder update from CEO Alan Joslyn outlining the Company’s vision and strategic growth strategy and highlights the significant accomplishments in 2016."
XON,XON:US,BBG000QL8VH9,ZIOPHARM to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-04 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-present-35th-annual-j-120000858.html,"[GlobeNewswire] - BOSTON, Jan. 04, 2017-- ZIOPHARM Oncology, Inc. today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 35 th Annual J.P. Morgan Healthcare Conference in San Francisco ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-03 13:00:00 +0000,http://finance.yahoo.com/news/intrexon-present-35th-annual-j-130000418.html,"[PR Newswire] - GERMANTOWN, Md., Jan. 3, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Office",2016-12-30 21:54:51 +0000,http://biz.yahoo.com/e/161230/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Office"
XON,XON:US,BBG000QL8VH9,"December 29, 2016 – Reverse share split update (PDF)",2016-12-29 22:22:05 +0000,http://www.publicnow.com/view/DABE820EDE67A5202BC696D40DF36CCE830134B9,"[at noodls] - 29 December 2016 AquaBounty Technologies Inc. (""AquaBounty"" or the ""Company"") Reverse Share Split Update AquaBounty Technologies, Inc. (AIM: ABTU), a biotechnology company focused on ..."
XON,XON:US,BBG000QL8VH9,Coverage initiated on Intrexon by Northland Capital,2016-12-29 14:13:56 +0000,http://finance.yahoo.com/q/ud?s=XON,Coverage initiated on Intrexon by Northland Capital
XON,XON:US,BBG000QL8VH9,Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies,2016-12-29 13:52:10 +0000,http://www.publicnow.com/view/CEF2368E068720F749BE2C251A182A4743406F5D,"[at noodls] - GERMANTOWN, Md., Dec. 29, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON)('Intrexon' or the 'Company'), a leader in the engineering and industrialization of biology to improve the quality of life ..."
XON,XON:US,BBG000QL8VH9,"December 21, 2016 – Debt conversion update (PDF)",2016-12-21 18:32:05 +0000,http://www.publicnow.com/view/FFBC57847AA43C655CBD87386EC5BB5148BAF8B0,"[at noodls] - 21 December 2016 AquaBounty Technologies Inc. (""AquaBounty"" or the ""Company"") Debt Conversion Update AquaBounty Technologies, Inc. (AIM: ABTU; OTC: AQBT), a biotechnology company focused ..."
XON,XON:US,BBG000QL8VH9,Weekly CEO Buys Highlight,2016-12-19 15:09:13 +0000,http://finance.yahoo.com/news/weekly-ceo-buys-highlight-150913623.html,Weekly CEO Buys Highlight
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Leadership Changes,2016-12-19 13:11:10 +0000,http://www.publicnow.com/view/8F20B98AEC53FD39C5410D3039665375A6B62E83,"[at noodls] - John Maslowski Succeeds David Pernock as Chief Executive Officer; Douglas Swirsky Appointed Chairman of the Board of Directors EXTON, Pa., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Leadership Changes,2016-12-19 13:00:00 +0000,http://finance.yahoo.com/news/fibrocell-announces-leadership-changes-130000247.html,"[GlobeNewswire] - John Maslowski Succeeds David Pernock as Chief Executive Officer; Douglas Swirsky Appointed Chairman of the Board of Directors. EXTON, Pa., Dec. 19, 2016-- Fibrocell Science, Inc. today announced that ..."
XON,XON:US,BBG000QL8VH9,How Intrexon Corp (XON) Stacks Up Against Its Peers,2016-12-18 18:16:57 +0000,http://www.insidermonkey.com/blog/how-intrexon-corp-xon-stacks-up-against-its-peers-509494/,How Intrexon Corp (XON) Stacks Up Against Its Peers
XON,XON:US,BBG000QL8VH9,"Noteworthy Friday Option Activity: XON, PXD, DECK",2016-12-16 21:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_mwaGDq2QmE/noteworthy-friday-option-activity-xon-pxd-deck-cm722748,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Intrexon Corp Symbol XON where a total volume of 4 813 contracts has been traded thus far today a contract volume which is representative of approximately 481 300
XON,XON:US,BBG000QL8VH9,CEO of Intrexon Invests in Company,2016-12-15 22:34:54 +0000,http://finance.yahoo.com/news/ceo-intrexon-invests-company-223454635.html,CEO of Intrexon Invests in Company
XON,XON:US,BBG000QL8VH9,Oragenics Presents Engineering of Improved Lantibiotic Variants at American Society for Microbiology (ASM) Conference on Antibacterial Development,2016-12-15 12:45:00 +0000,http://finance.yahoo.com/news/oragenics-presents-engineering-improved-lantibiotic-124500044.html,"[Business Wire] - Oragenics , a leader in the development of new antibiotics against infectious disease and developing effective treatments for oral mucositis, today announced it presented at the American Society for Microbiology Conference on Antibacterial Development held at the Omni Shoreham Hotel in Washington, DC, on Dec."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. – Value Analysis (NYSE:XON) : December 14, 2016",2016-12-14 16:18:05 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-value-analysis-nysexon-december-14-2016/,"Intrexon Corp. – Value Analysis (NYSE:XON) : December 14, 2016"
XON,XON:US,BBG000QL8VH9,Better Buy: Intrexon Corporation vs. bluebird bio,2016-12-14 13:36:26 +0000,http://www.fool.com/investing/2016/12/13/better-buy-intrexon-corporation-vs-bluebird-bio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Intrexon Corporation vs. bluebird bio
XON,XON:US,BBG000QL8VH9,Better Buy: Intrexon Corporation vs. bluebird bio,2016-12-13 16:58:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TLFZ0XUEnGI/better-buy-intrexon-corporation-vs-bluebird-bio-cm720837,Image source Getty Images Although the word biotech is often used interchangeably with biopharma biology as technology is not confined to healthcare applications That s the message engineered biology conglomerate Intrexon NYSE XON is trying to send out to investors Sure
XON,XON:US,BBG000QL8VH9,Intrexon Advances ActoBiotics™ Platform to Development Phase for Biological Crop Protection,2016-12-13 13:00:00 +0000,http://finance.yahoo.com/news/intrexon-advances-actobiotics-platform-development-130000431.html,"[PR Newswire] - DAVIS, Calif., Dec. 13, 2016 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced initial studies have validated the efficacy of dsRNA for insect control applications using its proprietary ActoBiotics™ platform. With this achievement, Intrexon's collaboration with a leading global agricultural company advances to its next phase of development for biological crop protection solutions. ""We are pleased by the early results showing this biological expression system to be a capable and potentially superior delivery vehicle for biologically active dsRNA as compared to alternative approaches,"" said Corey Huck, Senior Vice President and Head of Intrexon's Food Sector. New crop protection technologies are critical to address these issues and improve agricultural productivity. One such innovative, environmentally-friendly approach is the utilization of dsRNA to silence target genes in multiple insect species providing for a novel mechanism and mode of action in pest management strategies. The versatile ActoBiotics™ platform enables production of an array of targeted biologicals including dsRNA for crop protection."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : December 13, 2016",2016-12-13 12:46:11 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-december-13-2016/,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : December 13, 2016"
XON,XON:US,BBG000QL8VH9,"Synthetic Biologics Announces Granting of U.S. Composition of Matter Patent for SYN-005, Designed for the Treatment and Prevention of Pertussis (Whooping Cough)",2016-12-13 11:58:00 +0000,http://finance.yahoo.com/news/synthetic-biologics-announces-granting-u-115800358.html,"[PR Newswire] - ROCKVILLE, Md., Dec. 13, 2016 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced that the United States Patent Office has granted U.S. Patent No. 9,512,204 which provides composition of matter coverage for SYN-005, the Company's preclinical drug candidate designed to treat or prevent the development of Pertussis (whooping cough), especially in infants. This patent, which is co-owned with Synthetic Biologics' Pertussis academic collaborator, The University of Texas at Austin (UT Austin), is also exclusively licensed to Synthetic Biologics."
XON,XON:US,BBG000QL8VH9,Beware the Fear of Missing Out (FOMO),2016-12-12 21:00:00 +0000,http://realmoney.thestreet.com/articles/12/12/2016/beware-fear-missing-out-fomo?puc=yahoo&cm_ven=YAHOO,Beware the Fear of Missing Out (FOMO)
XON,XON:US,BBG000QL8VH9,Oxitec's Medfly Ready for Open Field Trials,2016-12-12 13:00:00 +0000,http://finance.yahoo.com/news/oxitecs-medfly-ready-open-field-130000746.html,"[PR Newswire] - Oxitec announced today that after a series of successful contained environment studies across multiple countries with its self-limiting Mediterranean fruit fly (Medfly), the Company is ready to move forward towards open field trials. The studies demonstrated the self-limiting Medfly's ability to successfully mate with wild Medfly and subsequently suppress the pest population. The efficacy of the Oxitec Medfly and existing control methods were also examined."
XON,XON:US,BBG000QL8VH9,Tuesday 12/6 Insider Buying Report: XON,2016-12-06 21:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n91tTAGwXzU/tuesday-126-insider-buying-report-xon-cm717418,Bargain hunters are wise to pay careful attention to insider buying because although there are many various reasons for an insider to sell a stock presumably the only reason they would use their hard earned dollars to make a purchase is that they expect to make money Today we look at
XON,XON:US,BBG000QL8VH9,Intrexon Director Recently Made Small Insider Buy,2016-12-05 22:17:54 +0000,http://finance.yahoo.com/news/intrexon-director-recently-made-small-221754123.html,Intrexon Director Recently Made Small Insider Buy
XON,XON:US,BBG000QL8VH9,Intrexon Corporation Surged 12% in November -- Here's Why,2016-12-02 14:23:05 +0000,http://www.fool.com/investing/2016/12/01/intrexon-corporation-surged-12-in-november-heres-w.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Intrexon Corporation Surged 12% in November -- Here's Why
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : December 2, 2016",2016-12-02 12:46:16 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-december-2-2016/,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : December 2, 2016"
XON,XON:US,BBG000QL8VH9,Intrexon Breaks Below 200-Day Moving Average - Notable for XON,2016-12-01 22:32:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ynfNm-w7Cdo/intrexon-breaks-below-200-day-moving-average-notable-for-xon-cm716636,In trading on Thursday shares of Intrexon Corp Symbol XON crossed below their 200 day moving average of 28 91 changing hands as low as 27 77 per share Intrexon Corp shares are currently trading down about 4 6 on the day The chart below shows the one year performance of XON shares
XON,XON:US,BBG000QL8VH9,Oxitec Announces Friendly™ Aedes Project is Supported By 92.8% of Piracicaba’s Population,2016-11-30 12:03:00 +0000,http://finance.yahoo.com/news/oxitec-announces-friendly-aedes-project-120300582.html,"[PR Newswire] - ""The growing popularity of Friendly™ Aedes in Piracicaba reflects the diligent work of public health agents and of Oxitec's team to explain what our mosquito is and how it works"", said Glen Slade, director of Oxitec do Brasil, the company that produces Friendly™ Aedes."
XON,XON:US,BBG000QL8VH9,Should You Avoid Owens-Illinois Inc (OI)?,2016-11-28 11:24:17 +0000,http://www.insidermonkey.com/blog/should-you-avoid-owens-illinois-inc-oi-2-493014/,Should You Avoid Owens-Illinois Inc (OI)?
XON,XON:US,BBG000QL8VH9,Oragenics Jumps on Fast Track Status for Oral Mucositis Drug,2016-11-23 15:07:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GqQeWI6wAHI/oragenics-jumps-on-fast-track-status-for-oral-mucositis-drug-cm713176,Oragenics Inc s OGEN shares skyrocketed 81 4 after the company announced that the FDA has granted Fast Track status to its lead candidate AG013 for the treatment of oral mucositis Shares further gained 2 6 in the subsequent trading session Overall the company s shares are up a
XON,XON:US,BBG000QL8VH9,3 Reasons Intrexon Corp. Stock Could Fall,2016-11-23 14:05:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1JRhy8DE6Yg/3-reasons-intrexon-corp-stock-could-fall-cm713129,Image source Getty Images Intrexon s NYSE XON sheer number of shots on goal shows tremendous promise for the engineered biology conglomerate Products in development or nearing commercial launch include everything from genetically engineered mosquitoes for public health to
XON,XON:US,BBG000QL8VH9,Oragenics Jumps on Fast Track Status for Oral Mucositis Drug,2016-11-23 13:18:01 +0000,http://finance.yahoo.com/news/oragenics-jumps-fast-track-status-131801377.html,Oragenics Jumps on Fast Track Status for Oral Mucositis Drug
XON,XON:US,BBG000QL8VH9,3 Reasons Intrexon Corp. Stock Could Fall,2016-11-23 12:14:43 +0000,http://www.fool.com/investing/2016/11/23/3-reasons-intrexon-corp-stock-could-fall.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Intrexon Corp. Stock Could Fall
XON,XON:US,BBG000QL8VH9,U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis,2016-11-21 20:29:00 +0000,http://finance.yahoo.com/news/u-fda-grants-fast-track-124500404.html,"[Business Wire] - Oragenics , a leader in the development of novel antibiotics against infectious disease and developing effective treatments for oral mucositis , today announced that the U.S."
XON,XON:US,BBG000QL8VH9,"Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida",2016-11-21 14:00:00 +0000,http://finance.yahoo.com/news/board-florida-keys-mosquito-control-140000936.html,"[PR Newswire] - Oxitec announced today the Board of the Florida Keys Mosquito Control District (FKMCD) voted to approve the investigational agreement for use of self-limiting Friendly™ mosquitoes in an effectiveness trial to fight against Aedes aegypti, the primary vector for many dangerous viruses including Zika, dengue, and chikungunya. This decision follows the November 8th approval vote by residents in Monroe County, clearly voicing their support for new solutions like Oxitec's in combatting this invasive, disease-carrying mosquito."
XON,XON:US,BBG000QL8VH9,U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis,2016-11-21 12:50:16 +0000,http://www.publicnow.com/view/6C8D519EC64733BB832CE8359EBDFC9769CBDD20,"[at noodls] - U.S. FDA Grants Fast Track Designation for the Development of Oragenics' AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the development of novel antibiotics ..."
XON,XON:US,BBG000QL8VH9,"WHO: Zika Is No Longer Global Emergency (INO, XON)",2016-11-21 12:28:00 +0000,http://www.investopedia.com/news/zika-drug-projects-stall-who-ends-emergency-ino/?partner=YahooSA,"WHO: Zika Is No Longer Global Emergency (INO, XON)"
XON,XON:US,BBG000QL8VH9,ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer,2016-11-17 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-announces-clinical-data-ad-120000609.html,[GlobeNewswire] - –Data to Be Presented at the 21 st Society for Neuro-Oncology Annual Meeting–. –Non-clinical Study Supports Initiation of New Clinical Trial of Ad-RTS-hIL-12 in Pediatric Brain Tumors–. –Company to Host ...
XON,XON:US,BBG000QL8VH9,3 Reasons Intrexon Corp. Stock Could Rise,2016-11-15 23:50:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i9cndzDqrf8/3-reasons-intrexon-corp-stock-could-rise-cm709749,Image source Getty Images Engineered biology conglomerate Intrexon NYSE XON has become a darling stock among biotech investors in the last year A portfolio of products obtained in numerous acquisitions have either been launched or are nearing commercialization While
XON,XON:US,BBG000QL8VH9,3 Reasons Intrexon Corp. Stock Could Rise,2016-11-15 22:12:06 +0000,http://www.fool.com/investing/2016/11/15/3-reasons-intrexon-corp-stock-could-rise.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Intrexon Corp. Stock Could Rise
XON,XON:US,BBG000QL8VH9,Sleeping Beauty System Used to Co-express CAR with Membrane-Bound IL-15 to Enhance Persistence of CD19-Specific T Cells,2016-11-15 12:08:09 +0000,http://www.publicnow.com/view/981406DAD2125C8B585C998624CD5C516BCE0D3B,"[at noodls] - BOSTON, Nov. 15, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced the publication of data demonstrating enhanced ..."
XON,XON:US,BBG000QL8VH9,Sleeping Beauty System Used to Co-express CAR with Membrane-Bound IL-15 to Enhance Persistence of CD19-Specific T Cells,2016-11-15 12:00:00 +0000,http://finance.yahoo.com/news/sleeping-beauty-system-used-co-120000834.html,"[GlobeNewswire] - BOSTON, Nov. 15, 2016-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced the publication of data demonstrating enhanced persistence of genetically modified ..."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss",2016-11-11 22:28:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2xcOTbwVkY/intrexon-xon-reports-in-line-loss-in-q3-revenues-miss-cm708141,Shares of Intrexon Corporation XON have risen more than 4 since it announced its third quarter results Intrexon reported a loss of 24 cents per share in third quarter 2016 which was in line with the Zacks Consensus Estimate However adjusted loss per share was 17 cents compared to
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss",2016-11-11 19:58:07 +0000,http://finance.yahoo.com/news/intrexon-xon-reports-line-loss-195807637.html,"Intrexon (XON) Reports In-Line Loss in Q3, Revenues Miss"
XON,XON:US,BBG000QL8VH9,/C O R R E C T I O N -- Intrexon Corporation/,2016-11-11 13:31:00 +0000,http://finance.yahoo.com/news/intrexon-present-stifel-2016-healthcare-130000735.html,"[PR Newswire] - In the news release, Intrexon to Present at the Stifel 2016 Healthcare Conference, issued 11-Nov-2016 by Intrexon Corporation over PR Newswire, the time of the presentation in the first paragraph should ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : November 11, 2016",2016-11-11 12:14:06 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bullish-manner-xon-us-november-11-2016/,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : November 11, 2016"
XON,XON:US,BBG000QL8VH9,The Reason Behind ZIOPHARM Oncology Inc.'s 11% Gain,2016-11-10 20:02:27 +0000,http://www.fool.com/investing/2016/11/10/the-reason-behind-ziopharm-oncology-incs-11-gain.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Reason Behind ZIOPHARM Oncology Inc.'s 11% Gain
XON,XON:US,BBG000QL8VH9,Intrexon Breaks Above 200-Day Moving Average - Bullish for XON,2016-11-10 19:13:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EEgHQi3eYw4/intrexon-breaks-above-200-day-moving-average-bullish-for-xon-cm707308,In trading on Thursday shares of Intrexon Corp Symbol XON crossed above their 200 day moving average of 28 96 changing hands as high as 29 37 per share Intrexon Corp shares are currently trading up about 2 6 on the day The chart below shows the one year performance of XON shares
XON,XON:US,BBG000QL8VH9,Intrexon 3Q Loss $29 Million or 24c/Share (XON),2016-11-10 17:55:00 +0000,http://www.investopedia.com/news/intrexon-3q-loss-24cshare-below-street-xon/?partner=YahooSA,Intrexon 3Q Loss $29 Million or 24c/Share (XON)
XON,XON:US,BBG000QL8VH9,Intrexon's Biggest Risk Front and Center in Third-Quarter 2016 Earnings,2016-11-10 15:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v7QiJKDzS2U/intrexons-biggest-risk-front-and-center-in-third-quarter-2016-earnings-cm707186,Image source Oxitec Engineered biology conglomerate Intrexon NYSE XON reported third quarter 2016 earnings with an extra dose of excitement on Wednesday an important update on its commercialization plans for genetically modified mosquitoes aimed at combating mosquito
XON,XON:US,BBG000QL8VH9,Intrexon's Biggest Risk Front and Center in Third-Quarter 2016 Earnings,2016-11-10 15:33:24 +0000,http://www.fool.com/investing/2016/11/10/intrexons-biggest-risk-front-and-center-in-third-q.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Intrexon's Biggest Risk Front and Center in Third-Quarter 2016 Earnings
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 14:45:55 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-xon-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"Intrexon Corp. :XON-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
XON,XON:US,BBG000QL8VH9,"Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor",2016-11-10 13:30:00 +0000,http://finance.yahoo.com/news/fibrocell-appoints-alfred-t-lane-133000556.html,"[GlobeNewswire] - EXTON, Pa., Nov. 10, 2016-- Fibrocell Science, Inc. today announced the appointment of Alfred T. Lane, MD, as Chief Medical Advisor of Fibrocell. A board certified dermatologist and pediatrician, Dr. Lane ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference,2016-11-10 12:00:00 +0000,http://finance.yahoo.com/news/ziopharm-present-jefferies-2016-london-120000382.html,"[GlobeNewswire] - BOSTON, Nov. 10, 2016-- ZIOPHARM Oncology, Inc. today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday, ..."
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 9-Nov-16 10:30pm GMT,2016-11-10 09:18:53 +0000,http://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-091853544.html,Edited Transcript of XON earnings conference call or presentation 9-Nov-16 10:30pm GMT
XON,XON:US,BBG000QL8VH9,Intrexon reports 3Q loss,2016-11-09 22:06:23 +0000,http://sg.finance.yahoo.com/news/intrexon-reports-3q-loss-220623261.html,Intrexon reports 3Q loss
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial",2016-11-09 21:19:19 +0000,http://biz.yahoo.com/e/161109/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial"
XON,XON:US,BBG000QL8VH9,Intrexon Announces Third Quarter 2016 Financial Results,2016-11-09 21:11:13 +0000,http://www.publicnow.com/view/C4C4801F00922166C90037DE0E86858B76BEE0E5,"[at noodls] - - Quarterly GAAP revenues of $49.0 million and net loss of $29.0 million including non-cash charges of $25.5 million - GERMANTOWN, Md., Nov. 9, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Reports Third Quarter 2016 Financial Results and Provides Update on Recent Activities,2016-11-09 21:05:00 +0000,http://finance.yahoo.com/news/ziopharm-reports-third-quarter-2016-210500066.html,"[GlobeNewswire] - BOSTON, Nov. 09, 2016-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced financial results for the third quarter ended September 30, 2016, and provided ..."
XON,XON:US,BBG000QL8VH9,"Earnings Reaction History: Intrexon Corporation, 33.3% Follow-Through Indicator, 8.9% Sensitive",2016-11-09 19:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/omoYup69r4w/earnings-reaction-history-intrexon-corporation-333-follow-through-indicator-89-sensitive-cm706708,Expected Earnings Release 11 09 2016 After hoursExpected Earnings Release 11 09 2016 After hours Avg Extended Hours Dollar Volume 1 687 937Avg Extended Hours Dollar Volume 1 687 937 Intrexon Corporation XON is due to issue its quarterly earnings report in the upcoming extended
XON,XON:US,BBG000QL8VH9,Monroe County Votes in Support of Florida Keys Mosquito Control District Conducting an Effectiveness Trial Utilizing Oxitec’s Genetically Engineered Mosquitoes,2016-11-09 13:00:00 +0000,http://finance.yahoo.com/news/monroe-county-votes-support-florida-130000733.html,"[PR Newswire] - Oxitec announces that the residents of Monroe County, Florida yesterday voted to support the Florida Keys Mosquito Control District utilizing Oxitec's genetically engineered, self-limiting mosquitoes in an effectiveness trial to fight against the Aedes aegypti mosquito. ""The voters of Monroe County have clearly spoken."
XON,XON:US,BBG000QL8VH9,Q3 2016 Intrexon Corp Earnings Release - After Market Close,2016-11-09 12:07:06 +0000,http://biz.yahoo.com/research/earncal/20161109.html?t=xon,Q3 2016 Intrexon Corp Earnings Release - After Market Close
XON,XON:US,BBG000QL8VH9,"Healthcare Stocks' Q3 Earnings on Nov 9: XON, MGLN, SGRY",2016-11-08 17:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tW5flUzXP4k/healthcare-stocks-q3-earnings-on-nov-9-xon-mgln-sgry-cm705685,The Q3 earnings season has reached its tail end with almost 85 of the companies having reported results The 423 S amp P 500 members that have reported combined account for 87 1 of the index s total market capitalization as per the latest Earnings Preview Total earnings for these companies
XON,XON:US,BBG000QL8VH9,"Healthcare Stocks' Q3 Earnings on Nov 9: XON, MGLN, SGRY",2016-11-08 13:39:01 +0000,http://finance.yahoo.com/news/healthcare-stocks-q3-earnings-nov-133901481.html,"Healthcare Stocks' Q3 Earnings on Nov 9: XON, MGLN, SGRY"
XON,XON:US,BBG000QL8VH9,Election Day Has Big Implications for Intrexon,2016-11-07 17:20:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dN0y7zaIEbQ/election-day-has-big-implications-for-intrexon-cm705021,Image source Oxitec On Tuesday ballots in the Florida Keys will include the question of whether or not to release genetically modified mosquitoes there that could control the spread of mosquito borne diseases such as Zika virus and yellow fever The two non binding
XON,XON:US,BBG000QL8VH9,Intrexon (XON): Will the Stock Pull a Surprise in Q3 Earnings?,2016-11-07 15:24:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZdA8mcyXDXs/intrexon-xon-will-the-stock-pull-a-surprise-in-q3-earnings-cm704951,Intrexon Corporation XON is scheduled to report third quarter 2016 results on Nov 9 after the market closes In the last reported quarter the company posted a negative surprise of 26 09 Let s see how things have shaped up before the announcement Factors to Consider Being
XON,XON:US,BBG000QL8VH9,Election Day Has Big Implications for Intrexon,2016-11-07 15:10:50 +0000,http://www.fool.com/investing/2016/11/07/election-day-has-big-implications-for-intrexon.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Election Day Has Big Implications for Intrexon
XON,XON:US,BBG000QL8VH9,Intrexon (XON): Will the Stock Pull a Surprise in Q3 Earnings?,2016-11-07 12:57:12 +0000,http://finance.yahoo.com/news/intrexon-xon-stock-pull-surprise-125712625.html,Intrexon (XON): Will the Stock Pull a Surprise in Q3 Earnings?
XON,XON:US,BBG000QL8VH9,"November 7, 2016 – Filing of Form 10 with the Securities and Exchange Commission and conditional equity subscription from Intrexon (PDF)",2016-11-07 12:04:07 +0000,http://www.publicnow.com/view/8E45FCFCE461AD51219D0857DEC74D1A468BD4F2,"[at noodls] - 7 November 2016 AquaBounty Technologies Inc. (""AquaBounty"" or the ""Company"") Filing of Form 10 with the Securities and Exchange Commission and conditional equity subscription from Intrexon ..."
XON,XON:US,BBG000QL8VH9,"AquaBounty Technologies Inc. (""AquaBounty"" or the ""Company"") Filing of Form 10 with the Securities and Exchange Commission and conditional equity subscription from Intrexon",2016-11-07 11:44:00 +0000,http://finance.yahoo.com/news/aquabounty-technologies-inc-aquabounty-company-114400473.html,"[PR Newswire] - OTC: AQBT), a biotechnology company focused on enhancing productivity in aquaculture and a majority-owned subsidiary of Intrexon Corporation (XON) (""Intrexon""), announces that it has filed a registration statement for its common shares (""Common Shares"") in the United States and has agreed to a conditional equity subscription from Intrexon. Further to the Company's announcement of 12 October 2016 that it had voluntarily withdrawn its registration statement on Form 10, initially filed with the U.S. Securities and Exchange Commission (""SEC"") on 25 April 2014, AquaBounty now announces that it has filed a new Form 10 (the ""New Registration Statement"") with the SEC to register its Common Shares pursuant to Section 12(b) of the Securities Exchange Act of 1934."
XON,XON:US,BBG000QL8VH9,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass,2016-11-05 01:00:00 +0000,https://www.thestreet.com/story/13882286/1/friday-wasn-t-bad-amazon-induced-woes-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,Friday Wasn't Bad; Amazon-Induced Woes: Best of Kass
XON,XON:US,BBG000QL8VH9,"Better Buy: Ziopharm Oncology, Inc. vs. Juno Therapeutics",2016-11-03 15:54:30 +0000,http://www.fool.com/investing/2016/11/03/better-buy-ziopharm-oncology-inc-vs-juno-therapeut.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Ziopharm Oncology, Inc. vs. Juno Therapeutics"
XON,XON:US,BBG000QL8VH9,ZIOPHARM Announces Four Presentations at the 2016 ASH Annual Meeting,2016-11-03 13:19:17 +0000,http://finance.yahoo.com/news/ziopharm-announces-four-presentations-2016-131917378.html,"[GlobeNewswire] - BOSTON, Nov. 03, 2016-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new cancer immunotherapies, today announced that four abstracts highlighting data from the Company’ s adoptive cell-based ..."
XON,XON:US,BBG000QL8VH9,Fibrocell Reports Third Quarter 2016 Financial Results and Recent Operational Highlights,2016-11-03 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-reports-third-quarter-2016-120000289.html,"[GlobeNewswire] - EXTON, Pa., Nov. 03, 2016-- Fibrocell Science, Inc. today reported financial results for the third quarter ended September 30, 2016 and recent operational highlights. Fibrocell will host a conference call ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Office",2016-11-03 10:06:35 +0000,http://biz.yahoo.com/e/161103/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Office"
XON,XON:US,BBG000QL8VH9,Intrexon to Announce Third Quarter 2016 Financial Results on November 9th,2016-11-02 12:10:14 +0000,http://www.publicnow.com/view/5FBADA6955A0F1CE87326F61FBA8DDF3891E32E0,"[at noodls] - GERMANTOWN, Md., Nov. 2, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Thursday, November 3, 2016 to Discuss Third Quarter 2016 Financial Results and Recent Operational Highlights",2016-10-31 20:13:24 +0000,http://www.publicnow.com/view/EEB5394D97A911F732B116B1B59694911DE89366,"[at noodls] - EXTON, Pa., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC) will report financial results for the third quarter ended September 30, 2016 and recent operational highlights on Thursday, ..."
XON,XON:US,BBG000QL8VH9,"Fibrocell to Host Conference Call and Webcast on Thursday, November 3, 2016 to Discuss Third Quarter 2016 Financial Results and Recent Operational Highlights",2016-10-31 20:01:00 +0000,http://finance.yahoo.com/news/fibrocell-host-conference-call-webcast-200100404.html,"[GlobeNewswire] - EXTON, Pa., Oct. 31, 2016-- Fibrocell Science, Inc. will report financial results for the third quarter ended September 30, 2016 and recent operational highlights on Thursday, November 3, 2016, before ..."
XON,XON:US,BBG000QL8VH9,Google and Microsoft Take Aim at Deadly Mosquitoes,2016-10-30 13:03:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R1owjMze0ko/google-and-microsoft-take-aim-at-deadly-mosquitoes-cm700725,Image source Oxitec Investors have become accustomed to Alphabet s NASDAQ GOOGL 160 wacky acquisitions and moonshot projects The reigning search engine champion has gotten involved in everything from self driving cars to autonomous flying wind turbines to robot dogs But
XON,XON:US,BBG000QL8VH9,Google and Microsoft Take Aim at Deadly Mosquitoes,2016-10-30 10:46:52 +0000,http://www.fool.com/investing/2016/10/30/google-and-microsoft-take-aim-at-deadly-mosquitoes.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Google and Microsoft Take Aim at Deadly Mosquitoes
XON,XON:US,BBG000QL8VH9,Peek Under The Hood: EQWM Has 14% Upside,2016-10-27 14:41:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-kkhvc7DsY0/peek-under-the-hood-eqwm-has-14-upside-cm699321,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
XON,XON:US,BBG000QL8VH9,Intrexon says Brazil mosquito laboratory could protect millions,2016-10-26 22:41:34 +0000,http://finance.yahoo.com/news/intrexon-says-brazil-mosquito-laboratory-224134116.html,Intrexon says Brazil mosquito laboratory could protect millions
XON,XON:US,BBG000QL8VH9,Oxitec Opens Large Scale Mosquito Production Facility in Brazil,2016-10-26 11:00:00 +0000,http://finance.yahoo.com/news/oxitec-opens-large-scale-mosquito-110000562.html,"[PR Newswire] - OXFORD, England, Oct. 26, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"Commit To Purchase Intrexon Corp At $17.50, Earn 16.6% Using Options",2016-10-25 17:26:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/goyQV8TaoZ0/commit-to-purchase-intrexon-corp-at-1750-earn-166-using-options-cm698021,Investors considering a purchase of Intrexon Corp Symbol XON stock but cautious about paying the going market price of 26 55 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January
XON,XON:US,BBG000QL8VH9,"Why Companies' Debt Spree Is Risky for Investors (WMT, XON)",2016-10-24 14:37:00 +0000,http://www.investopedia.com/news/why-soaring-corporate-debt-spree-risky-investors/?partner=YahooSA,"Why Companies' Debt Spree Is Risky for Investors (WMT, XON)"
XON,XON:US,BBG000QL8VH9,"Better Buy: Ziopharm Oncology, Inc. vs. Intrexon Corporation",2016-10-14 21:42:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VQApc10uy68/better-buy-ziopharm-oncology-inc-vs-intrexon-corporation-cm693695,Image source Getty Images The close relationship between Ziopharm Oncology NASDAQ ZIOP and Intrexon NYSE XON hasn t gone unnoticed by investors in fact it s impossible to overlook since the latter is likely responsible for a majority of the former s 660 million
XON,XON:US,BBG000QL8VH9,"Better Buy: Ziopharm Oncology, Inc. vs. Intrexon Corporation",2016-10-14 19:45:57 +0000,http://www.fool.com/investing/2016/10/14/better-buy-ziopharm-oncology-inc-vs-intrexon-corpo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Ziopharm Oncology, Inc. vs. Intrexon Corporation"
XON,XON:US,BBG000QL8VH9,Unusual activity: Rite Aid,2016-10-14 16:44:00 +0000,http://finance.yahoo.com/video/unusual-activity-rite-aid-164400887.html,Unusual activity: Rite Aid
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : October 13, 2016",2016-10-13 12:29:11 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-october-13-2016/,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : October 13, 2016"
XON,XON:US,BBG000QL8VH9,Sanofi Vaccines Unit Riding High on BARDA Zika Funding,2016-10-11 15:21:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0soUIAAyBiQ/sanofi-vaccines-unit-riding-high-on-barda-zika-funding-cm691771,Sanofi SNY boasts one of the world s leading vaccine operations with a strong portfolio comprising pediatric vaccines influenza vaccines adult and adolescent booster vaccines meningitis vaccines and travel and endemic vaccines The company also enjoys a solid position in both the
XON,XON:US,BBG000QL8VH9,"Final Trade: ABX, DB, XLU & XON",2016-10-10 21:58:00 +0000,http://finance.yahoo.com/video/final-trade-abx-db-xlu-215800331.html,"Final Trade: ABX, DB, XLU & XON"
XON,XON:US,BBG000QL8VH9,Here's Why Intrexon Gained 14.2% in September,2016-10-10 15:21:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N2p94sC2WMM/heres-why-intrexon-gained-142-in-september-cm691037,Image source Getty Images What happened Shares of Intrexon NYSE XON a company focused on synthetic biology 160 rose by more than 14 in the month of September according to data from S amp P Global Market Intelligence
XON,XON:US,BBG000QL8VH9,Here's Why Intrexon Gained 14.2% in September,2016-10-10 13:29:06 +0000,http://www.fool.com/investing/2016/10/10/heres-why-intrexon-gained-142-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Intrexon Gained 14.2% in September
XON,XON:US,BBG000QL8VH9,ZIOPHARM Presents Data Demonstrating Activation of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 in Patients with Advanced Breast Cancer,2016-10-10 11:23:09 +0000,http://www.publicnow.com/view/996BA3021DBEE269BB0FA3C265F1725AAE65B5B0,"[at noodls] - BOSTON, Oct. 10, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced the presentation of preliminary data from the Company's Phase 1b/2 study of Ad-RTS-hIL-12 + veledimex following ..."
XON,XON:US,BBG000QL8VH9,ZIOPHARM Presents Data Demonstrating Activation of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 in Patients with Advanced Breast Cancer,2016-10-10 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-presents-data-demonstrating-activation-110000577.html,"[GlobeNewswire] - BOSTON, Oct. 10, 2016-- ZIOPHARM Oncology, Inc. announced the presentation of preliminary data from the Company’ s Phase 1 b/2 study of Ad-RTS-hIL-12+ veledimex following standard chemotherapy for the ..."
XON,XON:US,BBG000QL8VH9,Alnylam's RNAi Failure Could Catch Monsanto Investors Off Guard,2016-10-07 21:43:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_FzBGnOjgz0/alnylams-rnai-failure-could-catch-monsanto-investors-off-guard-cm690548,Image source Getty Images The Nobel Prize made headlines on two occasions this week albeit for very different reasons As a handful of scientists across the globe joined an exclusive club of laureates the technology awarded the Nobel Prize in Physiology or Medicine in 2006 suffered
XON,XON:US,BBG000QL8VH9,Alnylam's RNAi Failure Could Catch Monsanto Investors Off Guard,2016-10-07 20:22:06 +0000,http://www.fool.com/investing/2016/10/07/alnylams-rnai-failure-could-catch-monsanto-investo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Alnylam's RNAi Failure Could Catch Monsanto Investors Off Guard
XON,XON:US,BBG000QL8VH9,Intrexon Corp Breaks Above 200-Day Moving Average - Bullish for XON,2016-10-03 21:43:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qpVaQ7PJvhM/intrexon-corp-breaks-above-200-day-moving-average-bullish-for-xon-cm688113,In trading on Monday shares of Intrexon Corp Symbol XON crossed above their 200 day moving average of 29 14 changing hands as high as 29 17 per share Intrexon Corp shares are currently trading up about 3 6 on the day The chart below shows the one year performance of XON shares versus
XON,XON:US,BBG000QL8VH9,First Ever Commercial Harvest of Okanagan Specialty Fruits' Arctic® Golden Apples Completed,2016-10-03 12:16:08 +0000,http://www.publicnow.com/view/A079DBA6826D4F35C25B7C648AEFF8CD8DFA78C2,"[at noodls] - SUMMERLAND, British Columbia, Oct. 3, 2016/PRNewswire / -- Okanagan Specialty Fruits (OSF) announced today that it has successfully completed the first commercial harvest of its non-browning Arctic Golden ..."
XON,XON:US,BBG000QL8VH9,First Ever Commercial Harvest of Okanagan Specialty Fruits' Arctic® Golden Apples Completed,2016-10-03 12:00:00 +0000,http://finance.yahoo.com/news/first-ever-commercial-harvest-okanagan-120000997.html,"[PR Newswire] - ""We are pleased to see over 20 years of hard work and effort coming to fruition with this first commercial harvest of our Arctic® Golden variety,"" said Neal Carter, founder and president of Okanagan Specialty Fruits."
XON,XON:US,BBG000QL8VH9,Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa,2016-09-29 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-present-2016-cell-gene-120000079.html,"[GlobeNewswire] - EXTON, Pa., Sept. 29, 2016-- Fibrocell Science, Inc., today announced that John Maslowski, Senior Vice President, Scientific Affairs of Fibrocell, will present at 9:15 am PDT on Thursday, October 6 at ..."
XON,XON:US,BBG000QL8VH9,Intrexon Funds Two Startups in New Venture (XON),2016-09-27 19:47:00 +0000,http://www.investopedia.com/news/intrexon-funds-two-startups-new-venture-xon/?partner=YahooSA,Intrexon Funds Two Startups in New Venture (XON)
XON,XON:US,BBG000QL8VH9,Intrexon Grants Employment Inducement Award Pursuant to NYSE Rule 303A.08,2016-09-26 22:19:03 +0000,http://www.publicnow.com/view/765D554A794475892134BD53DF861187279871D6,"[at noodls] - GERMANTOWN, Md., Sept. 26, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that pursuant to New York Stock Exchange Rule 303A.08 it granted Geno J. ..."
XON,XON:US,BBG000QL8VH9,Intrexon Grants Employment Inducement Award Pursuant to NYSE Rule 303A.08,2016-09-26 22:05:00 +0000,http://finance.yahoo.com/news/intrexon-grants-employment-inducement-award-220500625.html,"[PR Newswire] - GERMANTOWN, Md., Sept. 26, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that pursuant to New York Stock Exchange Rule 303A.08 it granted Geno J. ..."
XON,XON:US,BBG000QL8VH9,Surprising Analyst 12-Month Target For ONEK,2016-09-26 14:21:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vZnW6BBfDkU/surprising-analyst-12-month-target-for-onek-cm684452,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
XON,XON:US,BBG000QL8VH9,Lieutenant General (Ret.) Thomas P. Bostick to Lead Intrexon's Environment Sector,2016-09-26 12:09:03 +0000,http://www.publicnow.com/view/5E8FDC3C4613A5499453C8E516A6F5DE46374335,"[at noodls] - Former Commanding General of U.S. Army Corps of Engineers to Drive Worldwide Deployment of Oxitec's Friendly™ Mosquito GERMANTOWN, Md., Sept. 26, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), ..."
XON,XON:US,BBG000QL8VH9,Arctic® Fuji Gains USDA Approval,2016-09-26 11:00:00 +0000,http://finance.yahoo.com/news/arctic-fuji-gains-usda-approval-110000190.html,"[PR Newswire] - SUMMERLAND, British Columbia, Sept. 26, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of ..."
XON,XON:US,BBG000QL8VH9,3 Bold Bets on the Future of Biotechnology,2016-09-25 16:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7y-GJVbrQlM/3-bold-bets-on-the-future-of-biotechnology-cm684232,Image source Getty Images While we Fools generally invest in companies that are established and generating cash we also recognize that there s room for speculation in almost any portfolio After all companies that go on to create the next big thing can produce life changing
XON,XON:US,BBG000QL8VH9,3 Bold Bets on the Future of Biotechnology,2016-09-25 15:10:05 +0000,http://www.fool.com/investing/2016/09/25/3-bold-bets-on-the-future-of-biotechnology.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Bold Bets on the Future of Biotechnology
XON,XON:US,BBG000QL8VH9,"Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.",2016-09-24 13:21:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_HgkbjKwMjk/better-buy-ziopharm-oncology-inc-vs-alnylam-pharmaceuticals-inc-cm684147,IMAGE SOURCE GETTY IMAGES How good is any given stock It depends on your perspective Clinical stage biotechs Ziopharm Oncology NASDAQ ZIOP and Alnylam Pharmaceuticals NASDAQ ALNY for example have both suffered in 2016 Ziopharm s shares are down almost 20 year
XON,XON:US,BBG000QL8VH9,"Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.",2016-09-24 12:01:07 +0000,http://www.fool.com/investing/2016/09/24/better-buy-ziopharm-oncology-inc-vs-alnylam-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc."
XON,XON:US,BBG000QL8VH9,Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund,2016-09-23 12:12:03 +0000,http://www.publicnow.com/view/391103AE02266BA3291AD59B664886B117535104,"[at noodls] - Startups to Utilize ActoBiotics™ Platform to Develop Innovative Treatments for Celiac Disease and Chronic Rhinosinusitis GERMANTOWN, Md., Sept. 23, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), ..."
XON,XON:US,BBG000QL8VH9,"The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution",2016-09-19 15:01:01 +0000,http://www.fool.com/investing/general/2016/04/16/the-race-to-cure-the-zika-virus-is-on-and-this-com.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution"
XON,XON:US,BBG000QL8VH9,Fibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa,2016-09-19 12:00:00 +0000,http://finance.yahoo.com/news/fibrocell-completes-enrollment-nc1-cohort-120000588.html,"[GlobeNewswire] - EXTON, Pa., Sept. 19, 2016-- Fibrocell Science, Inc. today announced that two additional adult subjects were enrolled in the Phase I/II clinical trial of FCX-007 for the treatment of Recessive Dystrophic ..."
XON,XON:US,BBG000QL8VH9,Here's Why Food Security May Be One of the Best Investments of the 21st Century,2016-09-17 13:43:47 +0000,http://www.fool.com/investing/2016/09/17/heres-why-food-security-may-be-one-of-the-best-inv.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Food Security May Be One of the Best Investments of the 21st Century
XON,XON:US,BBG000QL8VH9,Non-Remedial Stocks Poised to Beat Zika,2016-09-16 21:39:00 +0000,http://www.investopedia.com/news/nonremedial-stocks-poised-beat-zika/?partner=YahooSA,Non-Remedial Stocks Poised to Beat Zika
XON,XON:US,BBG000QL8VH9,Biotherapeutics: A Long-Run Bet by Intrexon (XON),2016-09-15 17:20:00 +0000,http://www.investopedia.com/news/biotherapeutics-longrun-bet-intrexon-xon/?partner=YahooSA,Biotherapeutics: A Long-Run Bet by Intrexon (XON)
XON,XON:US,BBG000QL8VH9,Intrexon’s Mosquitoes to Hit Zika at Source (XON),2016-09-15 16:14:00 +0000,http://www.investopedia.com/news/intrexons-mosquitoes-hit-zika-source-xon/?partner=YahooSA,Intrexon’s Mosquitoes to Hit Zika at Source (XON)
XON,XON:US,BBG000QL8VH9,Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized in Development of New Gene Therapy Treatments,2016-09-13 12:00:00 +0000,http://finance.yahoo.com/news/exemplar-genetics-exegen-cystic-fibrosis-120000370.html,"[PR Newswire] - SIOUX CENTER, Iowa, Sept. 13, 2016 /PRNewswire/ -- Exemplar Genetics , a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, ..."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Stock Up, JMP Securities: Mosquito Authorization Could Boost Revenue",2016-09-08 17:51:00 +0000,https://www.thestreet.com/story/13698705/1/intrexon-xon-stock-up-jmp-securities-mosquito-authorization-could-boost-revenue.html?puc=yahoo&cm_ven=YAHOO,"Intrexon (XON) Stock Up, JMP Securities: Mosquito Authorization Could Boost Revenue"
XON,XON:US,BBG000QL8VH9,Insiders Bullish on Certain Holdings of XBI,2016-09-08 15:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yntYrCtZgos/insiders-bullish-on-certain-holdings-of-xbi-cm676157,A look at the weighted underlying holdings of the SPDR S amp P Biotech ETF XBI shows an impressive 12 3 of holdings on a weighted basis have experienced insider buying within the past six months Sarepta Therapeutics Inc Symbol SRPT which makes up 3 14 of the SPDR S amp P
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : September 8, 2016",2016-09-08 12:25:59 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bullish-manner-xon-us-september-8-2016/,"Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : September 8, 2016"
XON,XON:US,BBG000QL8VH9,Here's a Reason Why Intrexon (XON) Stock Is Gaining Today,2016-09-07 19:18:00 +0000,https://www.thestreet.com/story/13697320/1/here-s-a-reason-why-intrexon-xon-stock-is-gaining-today.html?puc=yahoo&cm_ven=YAHOO,Here's a Reason Why Intrexon (XON) Stock Is Gaining Today
XON,XON:US,BBG000QL8VH9,Florida politicians urge use of Intrexon GM mosquitoes for Zika,2016-09-07 19:09:58 +0000,http://finance.yahoo.com/news/florida-politicians-urge-intrexon-gm-190958685.html,"[Reuters] - Intrexon Corp said on Wednesday a bipartisan coalition of Florida politicians had urged the U.S. government to step up efforts to fight Zika, including sanctioning the emergency use of the company's genetically engineered mosquitoes. The Florida House members, led by Speaker-designate Richard Corcoran and Democratic leader-designate Janet Cruz, have written to the U.S. Department of Health and Human Services, seeking permission for the state and local governments to use the GM mosquito, the company said."
XON,XON:US,BBG000QL8VH9,Florida Speaker-Designate and House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology,2016-09-07 17:29:01 +0000,http://www.publicnow.com/view/D5DB76DA980F063705F2B1D68AABD0168BAE89F8,"[at noodls] - GERMANTOWN, Md., Sept. 7, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,Florida Speaker-Designate and House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology,2016-09-07 17:20:00 +0000,http://finance.yahoo.com/news/florida-speaker-designate-house-members-172000493.html,"[PR Newswire] - GERMANTOWN, Md., Sept. 7, 2016 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,Intrexon Investors Are Neglecting This Technology Platform,2016-09-06 22:18:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yb8fT4AXFno/intrexon-investors-are-neglecting-this-technology-platform-cm675242,Image source Flickr 160 user John Goode Investors and the media love the Zika virus fighting mosquitoes non browning apples and fast growing salmon now owned by engineered biology conglomerate Intrexon NYSE XON But the technology platforms that steal the
XON,XON:US,BBG000QL8VH9,Intrexon Investors Are Neglecting This Technology Platform,2016-09-06 20:36:52 +0000,http://www.fool.com/investing/2016/09/06/intrexon-investors-are-neglecting-this-technology.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Intrexon Investors Are Neglecting This Technology Platform
XON,XON:US,BBG000QL8VH9,Oxitec and Piracicaba City Hall Start Release of Friendly™ Aedes in Additional 10 Downtown Neighborhoods,2016-09-06 13:19:03 +0000,http://www.publicnow.com/view/0AB86DA88A7B6D69CC6C727BD8F8FB8914FFCB61,"[at noodls] - Deployment of mosquito control solution that fights primary vector of Zika, dengue, and chikungunya begins today São Judas utilizing this technology since July 2016 Oxford, UK, 6 September 2016 Oxitec ..."
XON,XON:US,BBG000QL8VH9,Oxitec and Piracicaba City Hall Start Release of Friendly™ Aedes,2016-09-06 13:09:00 +0000,http://finance.yahoo.com/news/oxitec-piracicaba-city-hall-start-130900545.html,[CNW Group] - Oxitec and Piracicaba City Hall Start Release of Friendly™ Aedes
XON,XON:US,BBG000QL8VH9,How to Cash in on the Fight Against the Zika Virus,2016-09-01 14:26:00 +0000,https://www.thestreet.com/story/13692136/1/how-to-cash-in-on-the-fight-against-the-zika-virus.html?puc=yahoo&cm_ven=YAHOO,How to Cash in on the Fight Against the Zika Virus
XON,XON:US,BBG000QL8VH9,Purcell Julie & Lefkowitz LLP Is Investigating Intrexon Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors,2016-09-01 11:21:00 +0000,http://finance.yahoo.com/news/purcell-julie-lefkowitz-llp-investigating-112100698.html,"[PR Newswire] - NEW YORK, Sept. 1, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Intrexon Corporation (XON)."
XON,XON:US,BBG000QL8VH9,These Two Companies Are Working On The Zika Virus Cure,2016-08-31 19:09:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dc30r_MYJbk/these-two-companies-are-working-on-the-zika-virus-cure-cm673032,"Mosquitoes have always sucked. They contribute basically nothing to the ecosystem, and they ruin just about every summer outdoor activity. I've hated mosquitoes long before I knew what the Zika virus was, and I'll hate them long"
XON,XON:US,BBG000QL8VH9,These Two Companies Are Working On The Zika Virus Cure,2016-08-31 16:57:04 +0000,http://finance.yahoo.com/news/two-companies-working-zika-virus-165704439.html,These Two Companies Are Working On The Zika Virus Cure
XON,XON:US,BBG000QL8VH9,ZIOPHARM to Present at the 2016 Wells Fargo Healthcare Conference,2016-08-31 11:00:00 +0000,http://finance.yahoo.com/news/ziopharm-present-2016-wells-fargo-110000881.html,"[GlobeNewswire] - BOSTON, Aug. 31, 2016-- ZIOPHARM Oncology, Inc. today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 2016 Wells Fargo Healthcare Conference on Wednesday, September ..."
XON,XON:US,BBG000QL8VH9,Ziopharm Has a Data Problem,2016-08-30 21:12:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WUPXckQzd_8/ziopharm-has-a-data-problem-cm672467,"Image source  Getty Images.  Clinical stage biopharma company Ziopharm (NASDAQ  ZIOP) has proven to be a frustrating stock to own in the last year, down 37%from January. Investors can chalk up some"
XON,XON:US,BBG000QL8VH9,Ziopharm Has a Data Problem,2016-08-30 19:49:51 +0000,http://www.fool.com/investing/2016/08/30/ziopharm-has-a-data-problem.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Ziopharm Has a Data Problem
XON,XON:US,BBG000QL8VH9,Inovio Stock Up as Second Zika Virus Vaccine Study Begins,2016-08-30 14:16:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D9s4jm9na7M/inovio-stock-up-as-second-zika-virus-vaccine-study-begins-cm672102,"Inovio Pharmaceuticals, Inc.INO announced that it has initiated the second study on its preventive Zika vaccine, GLS 5700, in Puerto Rico. The company's shares gained 4.6% on the news.  The placebo controlled, double blind study is"
XON,XON:US,BBG000QL8VH9,Inovio Stock Up as Second Zika Virus Vaccine Study Begins,2016-08-30 12:07:12 +0000,http://finance.yahoo.com/news/inovio-stock-second-zika-virus-120712989.html,Inovio Stock Up as Second Zika Virus Vaccine Study Begins
XON,XON:US,BBG000QL8VH9,Rosche's Zika test gets FDA emergency-use authorization,2016-08-29 20:20:00 +0000,http://finance.yahoo.com/video/rosches-zika-test-gets-fda-202000967.html,Rosche's Zika test gets FDA emergency-use authorization
XON,XON:US,BBG000QL8VH9,"Monday's ETF Movers: XME, XBI",2016-08-29 17:11:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z2NSM6xL18A/mondays-etf-movers-xme-xbi-cm671746,"In trading on Monday, the SPDR S&P Metals and Mining ETF is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares of Allegheny Technologies,"
XON,XON:US,BBG000QL8VH9,"Tampa biopharma’s $30M capital raise could aid people with infections, cancer",2016-08-26 18:42:52 +0000,http://www.bizjournals.com/tampabay/news/2016/08/26/tampa-biopharma-s-30m-capital-raise-could-aid.html?ana=yahoo,"Tampa biopharma’s $30M capital raise could aid people with infections, cancer"
XON,XON:US,BBG000QL8VH9,Value hunting in this year's worst perfomers,2016-08-26 16:50:00 +0000,http://finance.yahoo.com/video/value-hunting-years-worst-perfomers-165000147.html,Value hunting in this year's worst perfomers
XON,XON:US,BBG000QL8VH9,"ETF’s with exposure to Intrexon Corp. : August 26, 2016",2016-08-26 14:52:35 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-intrexon-corp-august-26-2016/,"ETF’s with exposure to Intrexon Corp. : August 26, 2016"
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : August 26, 2016",2016-08-26 12:16:02 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-breached-its-50-day-moving-average-in-a-bearish-manner-xon-us-august-26-2016/,"Intrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : August 26, 2016"
XON,XON:US,BBG000QL8VH9,The Implied Analyst 12-Month Target For JKK,2016-08-25 13:46:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2qh9308lPjE/the-implied-analyst-12-month-target-for-jkk-cm669957,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
XON,XON:US,BBG000QL8VH9,Oragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections,2016-08-23 12:28:04 +0000,http://www.publicnow.com/view/7CE182CC7CCA0BB205C673708F5D6CE8497CB53D,"[at noodls] - TAMPA, Fla.-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the development of new antibiotics against infectious disease and developing effective treatments for oral mucositis, today announced selection ..."
XON,XON:US,BBG000QL8VH9,What Zika Virus in Florida Means (and Doesn't Mean) for Intrexon,2016-08-19 15:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-4JVcBynrWM/what-zika-virus-in-florida-means-and-doesnt-mean-for-intrexon-cm667771,"Image source  Oxitec.  Experts predicted that Zika virus would eventually make its way to the continental United States, which boasts considerable populations of the Aedes aegypti mosquito that spreads the disease. It didn't"
XON,XON:US,BBG000QL8VH9,What Zika Virus in Florida Means (and Doesn't Mean) for Intrexon,2016-08-19 13:37:00 +0000,http://www.fool.com/investing/2016/08/19/what-zika-virus-in-florida-means-and-doesnt-mean-f.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Zika Virus in Florida Means (and Doesn't Mean) for Intrexon
XON,XON:US,BBG000QL8VH9,The Emperor Has No Clothes,2016-08-18 00:44:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/urPlzgri5pI/the-emperor-has-no-clothes-cm666819,"Why pay high fees to have somebody else gamble with your money?  Money manager Bill Miller just bought ""job security."" He now owns his fund management company. You canAAAt fire the boss. That doesnAAAt mean, though,"
XON,XON:US,BBG000QL8VH9,"Bullish bets on Intrexon, gold",2016-08-17 16:54:00 +0000,http://finance.yahoo.com/video/bullish-bets-intrexon-gold-165400759.html,"Bullish bets on Intrexon, gold"
XON,XON:US,BBG000QL8VH9,How calls are playing for rally in Intrexon,2016-08-17 15:24:28 +0000,http://finance.yahoo.com/news/traders-playing-intrexon-rally-152428341.html,How calls are playing for rally in Intrexon
XON,XON:US,BBG000QL8VH9,"ETF’s with exposure to Intrexon Corp. : August 15, 2016",2016-08-15 14:59:32 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-intrexon-corp-august-15-2016/,"ETF’s with exposure to Intrexon Corp. : August 15, 2016"
XON,XON:US,BBG000QL8VH9,Obama Moves Money Around To Keep Zika Research Going Amid Lack Of Congressional Funds Allocation,2016-08-12 17:24:24 +0000,http://finance.yahoo.com/news/obama-moves-money-around-keep-172424414.html,Obama Moves Money Around To Keep Zika Research Going Amid Lack Of Congressional Funds Allocation
XON,XON:US,BBG000QL8VH9,Why ZIOPHARM Oncology's Stock Broke Down in July,2016-08-11 14:51:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FbgmyrUT5ZQ/why-ziopharm-oncologys-stock-broke-down-in-july-cm663966,"Image source  Getty Images.  What ZIOPHARM Oncology (NASDAQ  ZIOP) , a clinical stage synthetic immuno oncology company, lost over 18% of its value last month, according to data from S&P Global Market Intelligence"
XON,XON:US,BBG000QL8VH9,"Intrexon Corp. :XON-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016",2016-08-11 14:21:17 +0000,http://www.capitalcube.com/blog/index.php/intrexon-corp-xon-us-earnings-analysis-q2-2016-by-the-numbers-august-11-2016/,"Intrexon Corp. :XON-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016"
XON,XON:US,BBG000QL8VH9,Why ZIOPHARM Oncology's Stock Broke Down in July,2016-08-11 13:26:00 +0000,http://www.fool.com/investing/2016/08/11/why-ziopharm-oncologys-stock-broke-down-in-july.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why ZIOPHARM Oncology's Stock Broke Down in July
XON,XON:US,BBG000QL8VH9,Arctic® Fuji apple one step closer to U.S. regulatory approval,2016-08-11 12:30:00 +0000,http://finance.yahoo.com/news/arctic-fuji-apple-one-step-123000282.html,"[PR Newswire] - SUMMERLAND, British Columbia, Aug. 11, 2016 /PRNewswire/ -- The U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) has publicly shared the final version of Okanagan Specialty Fruits Inc.'s (OSF) petition seeking regulatory approval for Arctic® Fuji apples, a nonbrowning variety produced through biotechnology. In an announcement published August 10, 2016, USDA APHIS stated that they have reached a preliminary decision to extend their determination of nonregulated status to OSF's nonbrowning Arctic® Fuji variety."
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase",2016-08-10 23:52:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8kBIiyi70tc/intrexon-xon-reports-wider-loss-in-q2-revenues-increase-cm663755,"Intrexon CorporationXON reported a loss of 42 cents per share in second quarter 2016, compared to the year ago figure of 37 cents. Excluding unrealized and realized appreciation (depreciation) in fair value of equity securities, loss came in at"
XON,XON:US,BBG000QL8VH9,Intrexon's Revenue Grows 17%. Here's Why Investors Should Be Worried.,2016-08-10 22:52:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xBrXy_-rhl4/intrexons-revenue-grows-17-heres-why-investors-should-be-worried-cm663726,Image source  George Redgrave  Flickr .  Engineered biology conglomerate Intrexon (NYSE  XON) reported second quarter earnings this week. While investors are more interested in the future than current financial results (Intrexon
XON,XON:US,BBG000QL8VH9,Intrexon's Revenue Grows 17%. Here's Why Investors Should Be Worried.,2016-08-10 21:11:00 +0000,http://www.fool.com/investing/2016/08/10/intrexons-revenue-grows-17-heres-why-investors-sho.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Intrexon's Revenue Grows 17%. Here's Why Investors Should Be Worried.
XON,XON:US,BBG000QL8VH9,"Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase",2016-08-10 21:10:09 +0000,http://finance.yahoo.com/news/intrexon-xon-reports-wider-loss-211009879.html,"Intrexon (XON) Reports Wider Loss in Q2, Revenues Increase"
XON,XON:US,BBG000QL8VH9,Intrexon CEO on Zika: We're working closely with FDA,2016-08-10 18:04:00 +0000,http://finance.yahoo.com/video/intrexon-ceo-zika-were-working-180400659.html,Intrexon CEO on Zika: We're working closely with FDA
XON,XON:US,BBG000QL8VH9,Edited Transcript of XON earnings conference call or presentation 9-Aug-16 9:30pm GMT,2016-08-10 05:14:48 +0000,http://finance.yahoo.com/news/edited-transcript-xon-earnings-conference-051448154.html,Edited Transcript of XON earnings conference call or presentation 9-Aug-16 9:30pm GMT
XON,XON:US,BBG000QL8VH9,Intrexon reports 2Q loss,2016-08-09 22:04:05 +0000,http://sg.finance.yahoo.com/news/intrexon-reports-2q-loss-220405067.html,Intrexon reports 2Q loss
XON,XON:US,BBG000QL8VH9,"The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways",2016-08-09 21:59:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HgcstxrQrRQ/the-zacks-analyst-blog-highlights-intrexon-pharmerica-surgery-partners-civitas-solutions-and-healthways-cm662530,"For Immediate Release Chicago, IL August 09, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"
XON,XON:US,BBG000QL8VH9,Intrexon Announces Second Quarter and First Half 2016 Financial Results,2016-08-09 20:30:14 +0000,http://www.publicnow.com/view/13DCF0109801E5A80BA536713B642AEC1FAFCBBE,"[at noodls] - - Quarterly revenues of $52.5 million and GAAP net loss of $49.1 million including non-cash charges of $44.0 million - GERMANTOWN, Md., Aug. 9, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-08-09 20:11:57 +0000,http://biz.yahoo.com/e/160809/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
XON,XON:US,BBG000QL8VH9,ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities,2016-08-09 20:01:00 +0000,http://finance.yahoo.com/news/ziopharm-reports-second-quarter-2016-200100353.html,"[GlobeNewswire] - BOSTON, Aug. 09, 2016-- ZIOPHARM Oncology, Inc. today announced financial results for the second quarter ended June 30, 2016, and provided an update on the Company’ s recent activities. ""ZIOPHARM ..."
XON,XON:US,BBG000QL8VH9,"After-Hours Earnings Report for August 9, 2016 :  DIS, MYL, MDVN, JAZZ, VSAT, TAHO, XON, DPLO, PCTY, FLTX, FSIC, WAGE",2016-08-09 19:11:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bxsqalmb0eo/after-hours-earnings-report-for-august-9-2016-dis-myl-mdvn-jazz-vsat-taho-xon-dplo-pcty-fltx-fsic-wage-cm662707,The following companies are expected to report earnings after hours on 08 09 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Walt Disney Company ( DIS ) is reporting for the
XON,XON:US,BBG000QL8VH9,"Earnings Reaction History: Intrexon Corporation, 40.0% Follow-Through Indicator, 9.1% Sensitive",2016-08-09 19:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nLHG43mIgLA/earnings-reaction-history-intrexon-corporation-400-follow-through-indicator-91-sensitive-cm662749,"Expected Earnings Release 08 09 2016, After hours Avg. Extended Hours Dollar Volume $1,581,397 Intrexon Corporation ( XON ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can expect"
XON,XON:US,BBG000QL8VH9,"The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways",2016-08-09 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-intrexon-133001369.html,"The Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways"
XON,XON:US,BBG000QL8VH9,Q2 2016 Intrexon Corp Earnings Release - After Market Close,2016-08-09 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20160809.html?t=xon,Q2 2016 Intrexon Corp Earnings Release - After Market Close
XON,XON:US,BBG000QL8VH9,Fibrocell Announces Proposed Public Offering of Common Stock and Warrants,2016-08-08 20:30:00 +0000,http://finance.yahoo.com/news/fibrocell-announces-proposed-public-offering-203000587.html,"[GlobeNewswire] - EXTON, Pa., Aug. 08, 2016-- Fibrocell Science, Inc. today announced that it intends to offer and sell shares of its common stock and related warrants to purchase shares of its common stock in an underwritten ..."
XON,XON:US,BBG000QL8VH9,"Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More",2016-08-08 15:19:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MTGNpesXygg/healthcare-stocks-aug-9-earnings-roster-xon-pmc-more-cm661800,Medical is one of the 10 sectors in the S&P 500 cohort that is expected to record growth in earnings in the second quarter. The sector is likely to post earnings growth of 4.4% on revenue improvement of 7.7%.
XON,XON:US,BBG000QL8VH9,"Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More",2016-08-08 13:09:01 +0000,http://finance.yahoo.com/news/healthcare-stocks-aug-9-earnings-130901546.html,"Healthcare Stocks' Aug 9 Earnings Roster: XON, PMC & More"
XON,XON:US,BBG000QL8VH9,Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer,2016-08-08 12:18:04 +0000,http://www.publicnow.com/view/081562911B2F8902CA9F96D28A20BA1F9196ACC1,"[at noodls] - GERMANTOWN, Md., Aug. 8, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-08-08 12:12:18 +0000,http://biz.yahoo.com/e/160808/xon8-k.html,"INTREXON CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
XON,XON:US,BBG000QL8VH9,What's in Store for Intrexon (XON) This Earnings Season?,2016-08-08 10:11:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WFF0QfQvCOE/whats-in-store-for-intrexon-xon-this-earnings-season-cm661583,"Intrexon CorporationXON is scheduled to report second quarter 2016 results on Aug 9, after market close. Intrexon's performance has been mostly disappointing with the company missing estimates in three of the four trailing quarters with an average miss of"
XON,XON:US,BBG000QL8VH9,What's in Store for Intrexon (XON) This Earnings Season?,2016-08-08 08:09:08 +0000,http://finance.yahoo.com/news/whats-store-intrexon-xon-earnings-080908109.html,What's in Store for Intrexon (XON) This Earnings Season?
XON,XON:US,BBG000QL8VH9,Watch these biotechs as the Zika virus moves to the U.S.,2016-08-06 16:11:05 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D9EBA3C2-5A46-11E6-B86D-AB1E4238803A&siteid=yhoof2,Watch these biotechs as the Zika virus moves to the U.S.
XON,XON:US,BBG000QL8VH9,GM mosquito trial will not significantly impact environment-FDA,2016-08-05 17:03:16 +0000,http://finance.yahoo.com/news/gm-mosquito-trial-not-significantly-170316299.html,GM mosquito trial will not significantly impact environment-FDA
XON,XON:US,BBG000QL8VH9,"MKS Instruments, Emerson Electric, Inovio Pharmaceuticals and Intrexon highlighted as Zacks Bull and Bear of the Day",2016-08-05 15:38:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z7hsgUq86Sw/mks-instruments-emerson-electric-inovio-pharmaceuticals-and-intrexon-highlighted-as-zacks-bull-and-bear-of-the-day-cm661153,"For Immediate Release Chicago, IL August 05, 2016 Zacks Equity Research highlights MKS Instruments ( MKSI ) as the Bull of the Day and Emerson Electric ( EMR ) as the Bear of the Day. In addition, Zacks Equity"
XON,XON:US,BBG000QL8VH9,These Two Companies Are Working On The Zika Virus Cure,2016-08-04 19:53:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_iYwYepVXs4/these-two-companies-are-working-on-the-zika-virus-cure-cm660647,"Mosquitoes have always sucked. They contribute basically nothing to the ecosystem, and they ruin just about every summer outdoor activity. I've hated mosquitoes long before I knew what the Zika virus was, and I'll hate them long after we"
XON,XON:US,BBG000QL8VH9,Intrexon to Announce Second Quarter and First Half 2016 Financial Results on August 9th,2016-08-02 12:21:13 +0000,http://www.publicnow.com/view/D0ED38A05360C7630335402D27D8F80B8B897620,"[at noodls] - GERMANTOWN, Md., Aug. 2, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON) today announced it will release second quarter and first half 2016 financial results after the market closes on Tuesday, August ..."
XON,XON:US,BBG000QL8VH9,"Commit To Buy Intrexon Corp At $12.50, Earn 15.2% Using Options",2016-07-27 17:25:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CSpByu0qPpQ/commit-to-buy-intrexon-corp-at-1250-earn-152-using-options-cm655807,"Investors eyeing a purchase of Intrexon Corp (Symbol XON) shares, but tentative about paying the going market price of $24.83 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in"
XON,XON:US,BBG000QL8VH9,Intrexon Introduces Florian™ Switch Technology for Flowering Control,2016-07-25 12:18:01 +0000,http://www.publicnow.com/view/757CEE181FF300D174ECB7AF8833341E3851B257,"[at noodls] - DAVIS, Calif., July 25, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today ..."
XON,XON:US,BBG000QL8VH9,Surprising Analyst 12-Month Target For JKK,2016-07-21 14:14:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mEJ6ofLnjFI/surprising-analyst-12-month-target-for-jkk-cm652581,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
XON,XON:US,BBG000QL8VH9,Intrexon's Genetically Engineered Mosquitoes (Finally) Have Data. What's Next?,2016-07-21 14:13:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5qeGeK2YwcI/intrexons-genetically-engineered-mosquitoes-finally-have-data-whats-next-cm652465,"Self limiting mosquitoes being released in Piracicaba, Brazil. Image source  Intrexon.  Using genetically engineered mosquitoes as a tool to combat mosquito borne diseases has faced one major critique to date  While scientists"
XON,XON:US,BBG000QL8VH9,"Noteworthy Monday Option Activity: PBI, XON, SBGI",2016-07-18 17:09:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Okq-z0pJA-M/noteworthy-monday-option-activity-pbi-xon-sbgi-cm650647,"Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Pitney Bowes Inc (Symbol PBI), where a total volume of 24,062 contracts has been traded thus far today, a contract volume"
XON,XON:US,BBG000QL8VH9,ZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I,2016-07-18 16:15:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O34PuMuWaPA/ziopharm-ziop-stock-down-on-patient-death-in-phase-i-cm650609,"ZIOPHARM Oncology, Inc. 's ZIOP shares crashed 11.6% after the company announced the death of a patient in a phase I study on its lead candidate, Ad RTS hIL 12, for the treatment of recurrent or progressive glioblastoma (GBM)"
XON,XON:US,BBG000QL8VH9,Oxitec Named Social Impact Investment of the Year,2016-07-07 19:31:02 +0000,http://www.publicnow.com/view/8682E0D5FB4EF5120E9A9A59644FE1B28856E40C,"[at noodls] - Oxford, UK, 7 July 2016 - Oxitec is delighted to have been named Social Impact Investment of the Year at the UK Business Angels Association (UKBAA) Angel Investment Awards 2016. The award recognises companies ..."
XON,XON:US,BBG000QL8VH9,Intrexon and ZIOPHARM Amend Exclusive Channel Collaborations to Improve Alignment as Programs Advance through Development,2016-06-30 12:21:07 +0000,http://www.publicnow.com/view/85C4AE48703068F735EE9A0A1683F8CC91CEA2A0,"[at noodls] - GERMANTOWN, Md. and BOSTON, June 30, 2016 (GLOBE NEWSWIRE) -- Intrexon Corporation (NYSE:XON), a leader in synthetic biology, and ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Present at the Jefferies 2016 Healthcare Conference,2016-06-10 12:09:01 +0000,http://www.publicnow.com/view/4FB479DD493B9DC13F1D1CCA9F4AEAC10D005534,"[at noodls] - GERMANTOWN, Md., June 10, 2016/PRNewswire /-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Announces Retirement of Samuel Broder, M.D., Head of Health Sector",2016-06-06 12:08:01 +0000,http://www.publicnow.com/view/337B3ADA0C99BD63F4EC333FDB7236A1A5B707F2,"[at noodls] - GERMANTOWN, Md., June 6, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the retirement of Samuel Broder, M.D., Senior Vice President and Head of Intrexon's ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Present at Upcoming Investor and Industry Conferences,2016-05-23 12:16:10 +0000,http://www.publicnow.com/view/ECD87D126A6F3690239B974D1496EBF80EFFD43F,"[at noodls] - GERMANTOWN, Md., May 23, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it will present at the following upcoming investor and industry conferences: ..."
XON,XON:US,BBG000QL8VH9,Intrexon Appoints Geno Germano to New Role of President,2016-05-17 12:42:07 +0000,http://www.publicnow.com/view/8F14F451C1129DEF3C6B4DAA6E50429DC2938ABC,"[at noodls] - GERMANTOWN, Md., May 17, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Geno Germanoto the new role of President of Intrexon effective ..."
XON,XON:US,BBG000QL8VH9,Intrexon reports 1Q loss,2016-05-10 21:42:42 +0000,http://sg.finance.yahoo.com/news/intrexon-reports-1q-loss-214242362.html,Intrexon reports 1Q loss
XON,XON:US,BBG000QL8VH9,Intrexon Announces First Quarter 2016 Financial Results,2016-05-10 20:28:17 +0000,http://www.publicnow.com/view/6CB250FE664C5DAD7EF3BE6463992451DCAEFADC,"[at noodls] - - Quarterly revenues of $43.4 million and GAAP net loss of $64.4 million including non-cash charges of $50.6 million - - Consideration received for technology access fees, reimbursement of R&D services ..."
XON,XON:US,BBG000QL8VH9,Intrexon Establishes Crop Protection Enterprise,2016-05-04 12:40:03 +0000,http://www.publicnow.com/view/CE59CCF1BA8705BF423C201211F6B662A962A9F5,"[at noodls] - DAVIS, Calif., May 4, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the formation of Intrexon Crop Protection (ICP), a wholly-owned subsidiary dedicated ..."
XON,XON:US,BBG000QL8VH9,Intrexon to Announce First Quarter 2016 Financial Results on May 10th,2016-04-28 12:19:14 +0000,http://www.publicnow.com/view/4D398A7B1A00FD171332F5AB3B8C52F2E8F70721,"[at noodls] - GERMANTOWN, Md., April 28, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON) today announced it will release first quarter 2016 financial results after the market closes on Tuesday, May 10, 2016. The ..."
XON,XON:US,BBG000QL8VH9,Intrexon Provides Update on Recent Stock Trading Activity,2016-04-22 11:25:07 +0000,http://www.publicnow.com/view/8FD4186C426DF8D2399E17FE8A05731A8B84638A,"[at noodls] - GERMANTOWN, Md., April 22, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, provided an update to its shareholders regarding recent trading activity in the company's ..."
XON,XON:US,BBG000QL8VH9,Fibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB),2016-04-18 13:02:08 +0000,http://www.publicnow.com/view/6EAA48567E35934408BBD57126F2CD07E9B8C1EA,"[at noodls] - EXTON, PA and GERMANTOWN, MD - April 18, 2016 - Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting ..."
XON,XON:US,BBG000QL8VH9,Intrexon Forms Two New Collaborations with Harvest Intrexon Enterprise Fund,2016-04-13 12:24:14 +0000,http://www.publicnow.com/view/EE64E716FAE097EB306AF2E980BD1D418464AAB7,"[at noodls] - GERMANTOWN, Md., April 13, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into Exclusive Channel Collaborations (ECC) with two startups ..."
XON,XON:US,BBG000QL8VH9,Intrexon Forms Collaboration to Develop Treatment for Type 1 Diabetes,2016-04-04 12:27:28 +0000,http://www.publicnow.com/view/510EFD2D6F943BBEF28A596A8CEC5F1369A8DE02,"[at noodls] - Joint Venture to Utilize ActoBiotics® Platform for Antigen-Specific Immunotherapy GHENT, Belgium, April 4, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced ..."
XON,XON:US,BBG000QL8VH9,Intrexon Pilot Plant for its Methanotroph Bioconversion Platform Now Operational,2016-03-30 12:21:50 +0000,http://www.publicnow.com/view/82594AED4BECE8D42317A46F30FD575E4D8DBC25,"[at noodls] - SOUTH SAN FRANCISCO, Calif., March 30, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the pilot plant for its proprietary gas-to-liquids bioconversion ..."
XON,XON:US,BBG000QL8VH9,"Intrexon Realigns Responsibilities, Augments Team",2016-03-21 10:57:07 +0000,http://www.publicnow.com/view/4BEFC5DCE2B9CD2329FA5C011CA9AA02EA33019E,"[at noodls] - GERMANTOWN, Md., March 21, 2016/PRNewswire / -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced a realignment of management responsibilities in response to the successful ..."
XON,XON:US,BBG000QL8VH9,Intrexon reports 4Q loss,2016-02-29 21:33:27 +0000,http://sg.finance.yahoo.com/news/intrexon-reports-4q-loss-213327131.html,Intrexon reports 4Q loss
XON,XON:US,BBG000QL8VH9,Intrexon tops Street 1Q forecasts,2015-05-11 21:52:05 +0000,http://sg.finance.yahoo.com/news/intrexon-tops-street-1q-forecasts-215205896.html,Intrexon tops Street 1Q forecasts
XON,XON:US,BBG000QL8VH9,Norcraft and Auspex are big market movers,2015-03-30 20:25:26 +0000,http://sg.finance.yahoo.com/news/norcraft-auspex-big-market-movers-202526668.html,Norcraft and Auspex are big market movers
XON,XON:US,BBG000QL8VH9,Shake-up at AstraZeneca as two immuno-oncology leaders leave,2015-01-05 17:03:44 +0000,http://sg.finance.yahoo.com/news/shake-astrazeneca-two-immuno-oncology-170344298.html,Shake-up at AstraZeneca as two immuno-oncology leaders leave
